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Brucellosis caused by Brucella spp. and Brucella abortus has been known as a 
causative organism of zoonotic disease. B. abortus causes undulant fever, 
endocarditis, arthritis and osteomyelitis in man and abortion and infertility in cattle. 
It easily infects not only animals by ingestion or inhalation bacterium in reproductive 
tissues, fetal fluids, and mammary gland, but also a man by direct or indirect contact 
with abortion related discharges and ingestion of unpasteurized dairy products from 
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the infected animals.  
B. abortus which invaded into the hosts through various pathways constructs 
autologous protection systems to avoid host cell immune system. In addition, the 
bacterium has been using various factors such as Brucella-containing vacuole (BCV), 
Type IV secretion system (T4SS), Cyclic β-1,2-glucan (cβG), Brucella-
lipopolysaccharide (Br-LPS) to induce survival/replication of the organism in the 
host cells. Moreover, it interferes with the signaling pathways of phagocytic cells by 
regulation of the expression of cytokines in the immune cells of the host cells. A 
number of studies have been carried out for the prevention and eradication of 
brucellosis that allows such stealthy invasion and survival/replication. In particular, 
the mechanism of invasion into host cells and the analysis of immunological 
characteristics are actively investigated.  
Currently, efforts to detect early infection of B. abortus have been made. Cellular 
proteins of B. abortus have been received attention as diagnostic antigens through 
the studies. Based on current knowledge, cellular proteins as recombinant form were 
used to compare the expression of various genes, especially genes related with 
cytokines by stimulation of immune cells derived from different host. Also, this 
study attempted to generate basic information on the development of new diagnostic 
method(s) and vaccine candidate in B. abortus infection.   
First, the expressions of IL-1β, IL-4, IL-6, IL-12p40, IFN-γ, TNF-α and iNOS 
were analyzed in bovine peripheral blood mononuclear cells. Also, the expression of 
Bax, Bcl-2 and TLR4 was analyzed after stimulation with B. abortus antigens (rMdh, 
 iii 
rOMP28, rRocF, rTsf and r0628). Each B. abortus antigens induced different patterns 
of cytokine expression depending on stimulation time and doses of antigens. 
Although IL-1β, IL-4, TNF-α and iNOS gene expressions were not observed, the 
expressions of IL-6, IL-12p40 and IFN-γ were induced in all stimulated B. abortus 
antigens (P < 0.05). The expression of apoptotic genes was not changed except TLR4 
(P < 0.05). 
Second, RAW 264.7 cells, a mouse macrophage cell-line, and mice were 
stimulated with B. abortus antigens (rMdh, rOMP10, rOMP19, rOMP28, rRocF and 
rTsf) to confirm the difference of immune responses in in vitro and in vivo. Changes 
in cytokine production were examined by stimulating with the cellular proteins in 
both RAW 264.7 cells and naive splenocytes. The immune response was analyzed 
by ELISA and ELISpot after immunization of mice with the B. abortus antigens 
(rMdh, rOMP10, rOMP19, rOMP28, rRocF and rTsf). The production of cytokines 
such as TNF-α and IL-6 was increased in stimulated RAW 264.7 cells (P < 0.05) 
while Th1-related cytokines, IFN-γ and IL-2, were induced in naive splenocytes (P 
< 0.01). In addition, the immune responses induced by the B. abortus antigens were 
compared by analyzing the in vivo immune response through the difference of IgG 
secretory cells. As a result, IgG production on the 28th day was significantly 
increased by immunization with those antigens (P < 0.05). 
Last, it was studied that the difference in immune responses generated by 
stimulated with B. abortus antigens (rMdh, rOMP10, rOMP19, rRocF and rTbpA) 
in THP-1 cells, human-derived leukemic monocytes. In particular, it was 
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investigated to focus on the expression of major immune-regulating factors that play 
important roles in innate immunity, such as cytokines and Toll-like receptors (TLRs), 
and acquired immunity in the host. After stimulation of THP-1 cells with B. abortus 
antigens, intracellular cytokine production and TLR expression were increased at 
different time points (12 and 24 h), and the differences were analyzed by quantified 
using ELISA and real-time RT-PCR, respectively (P < 0.05). In the expression of 
cytokines, it was observed that the production levels of TNF-α and IL-6 were 
induced at high levels in THP-1 cells stimulated with B. abortus antigens (P < 0.05). 
In addition, expression of TLR8 was significantly increased at 12 h after stimulation 
with rOMP19 and rMdh (P < 0.05). These results suggest the need for further studies 
on how the two B. abortus antigens, rOMP19 and rMdh, are involved in the 
expression of TLR8 within THP-1 cells.  
The results of these studies with immune cells derived from different hosts using 
the B. abortus antigens (rMdh, rTsf, rRocF, r0628, rTbpA, rOMP10, rOMP19 and 
rOMP28) showed that many of B. abortus cellular antigens showed higher 
antigenicity in different hosts. It indicated that rMdh and rOMP19 of these B. abortus 
antigens exhibits higher immunogenicity than other antigens. In particular, rMdh 
showed the highest immunogenicity to all immune cells used in this study. This study 
demonstrated the possibility of B. abortus antigen as an intracellular immune 
response modulator as well as a candidate for high immunogenicity antigens. 
Therefore, these findings would be useful for understanding basic immune responses, 
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General Introduction 
 
Brucellosis caused by Brucella, which is Gram-negative and has two 
chromosomes, is well known as a common zoonosis. Twelves of Brucella species 
have been identified since the first known brucellosis in 1908 as Malta fever; 
Brucella melitensis (sheep and goats), B. suis (hogs), B. abortus (cattle), B. ovis 
(sheep), B. canis (dog), B. neotomae (wood rats), B. ceti (seals), B. pinnipedialis 
(pinnipeds), B. inopinata (Breast implant infection), B. microti (common vole), B. 
vulpis (red fox), and B. papionis (baboon) [Foster et al., 2007; Ko et al., 2003, Scholz 
et al., 2010; Whatmore et al., 2014; Scholz et al., 2008; Scholz et al., 2016]. It is 
also known that Brucella penetrates into cells and is capable of proliferation. 
Abortion and infertility are known to be typical clinical symptoms of brucellosis in 
livestock, and osteoarticular (ie, peripheral arthritis, sacroiliitis, spondylitis) is 
known to occur in human infection [Baladi et al., 2013]. 
The immune response at the cellular level in Brucella infections is the earliest 
defense system. In particular, studies on the intracellular immune response using B. 
abortus have been performed recently, and studies on the changes of immune 
responses from the early stage of infection to the time course have been actively 
conducted [Mol et al., 2014; Hielpos et al., 2018]. Furthermore, various studies have 
been reported on various changes in intracellular invasion of Brucella [Ferrero et al., 
2012; Scian et al., 2012; Li et al., 2015; Reyes et al., 2017]. Several studies have 
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been reported on the differences in the amount of cytokine expression by immune 
cell stimulation using Brucella recombinant protein, the difference in expression 
protein in the microarray, and the immunological induction ability according to 
changes in immunoglobulin [Tan et al., 2012; Tian et al., 2013; Im et al., 2016a; Im 
et al., 2016b; Im et al., 2017; Im et al., 2018a; Im et al., 2018b; Shim et al., 2018; 
Soh et al., 2019]. In addition, in the experiment using the Brucella mutant, the 
immune responses in the cells through the control and mutation stimuli were 
analyzed to show differences in specific protein changes in the cells of Brucella [Tian 
et al., 2014; Park et al., 2018; Jung et al., 2018; Li et al., 2018]. 
In the case of brucellosis, an intracellular bacterium, immune responses of host 
cells can be avoided after penetration into cells. In other words, this stealthy ability 
of Brucella is able to make possible to penetrate and replicate within the cell. In 
Brucella, Brucella-containing vacuole (BCV), Type IV secretion system (T4SS), 
Cyclic β-1,2-glucan (cβG), and Brucella lipopolysaccharide (Br-LPS) play a major 
role to avoid immune mechanism within the host. Some studies have been reported 
on the intracellular changes of Brucella host invasion using mice [Alva-Pérez et al., 
2014; Vitry et al., 2014; Reyes et al., 2017]. In particular, infection with Brucella is 
identified in three steps in a mouse. The first step is the step of invasive the host by 
the bacteria, which usually occurs primarily within two days of infection. The second 
stage is the period of bacterial invasion into host cells, replication in the 
reticuloendothelium and reproductive organs, which occurs mainly between two 
weeks and three weeks, in the acute phase. The last step is a chronic stage with 
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duration of up to six months to a year, with long-term pathologic symptoms in organs 
[Plommet et al., 1988; Martirosyan et al., 2011; Grillo et al., 2012; Martirosyan and 
Gorvel, 2013]. Through the stealthy survival and replication ability of Brucella, it is 
possible for Brucella to stay in the host cells for long periods of time. Thus, studies 
have been actively conducted to analyze the roles of certain Brucella elements and 
to control them to treatment of brucellosis and to find vaccine candidates [Vishnu et 
al., 2015; Truong et al., 2016; Kim et al., 2017].  
Many studies have been conducted to analyze the intracellular mechanism and 
immune response of brucellosis. This study tried to analyze the immune response 
from various immune cells after stimulation of Brucella recombinant proteins. First, 
bovine peripheral blood mononuclear cells (bPBMCs) were stimulated with 
recombinant proteins and the expression of cytokines and genes in the cells was 
analyzed by real-time PCR. Second and third, the immune response in mouse 
macrophage cells (RAW 264.7 cells) stimulated with Brucella cellular proteins and 
the immune response in RAW 264.7 cells after stimulation with Brucella outer 
membrane proteins were analyzed, respectively. Finally, the immune responses of 
human leukemic monocyte cells (THP-1 cells) were analyzed after stimulation of the 
Brucella recombinant proteins.  
Therefore, the aim of this study was to investigate immune response regulating 
activity of Brucella cellular antigens and its potential as diagnosis and/or vaccine 
candidate using the Brucella cellular antigens through these studies.
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Literature Review 
 
I. BRUCELLA PATHOGENESIS 
 
1.1. Origin of Brucella 
Brucellosis, which is still occurring in many parts of the world, is known to be 
caused by Brucella as a common infectious disease. This persistent brucellosis 
causes economic problems such as reduced breeding and production in animals. At 
the beginning of 1960, only three species of Brucella, B. abortus, B. melitensis, and 
B. suis, were classified. Later, Brucella species were categorized more through 
continuous Brucella studies and up to now, twelve Brucella species have been 
categorized from different hosts (Table 1) [El-sayed and Awad, 2018]. 
In general, for humans, the infection of Brucella occurs through the consumption 
of unsterilized dairy products produced from livestock infected with brucellosis, or 
through direct contact with tissues or bodily fluids of infected animals. It can also be 
transmitted through the surface of the mucosa and infected by carelessly being 
stabbed by the needles of the brucellosis vaccine. Infections caused by breast milk 
or sexually transmitted diseases between humans and humans are rare [Celebi et al., 
2007; Meltzer et al., 2010].
 - 5 - 
Table 1. List of different Brucella species and their natural hosts 
Brucella species Colony type Natural host Zoonoses Year of first isolation 
B. melitensis (bv1-3) Smooth Goat and sheep +++ Bruce (1893) 
B. abortus (bv 1–6, 7, 9) Smooth Cattle ++ Schmidt (1901) 
B. suis biovar    Huddleson (1929) 
B. suis (bv 1–3) Smooth Pig ++  
B. suis (bv 2) Smooth Wild boar, Hare +  
B. suis (bv 4) Smooth Reindeer, Caribou ++  
B. suis (bv 5) Smooth Rodent –  
B. ovis Rough Sheep – Buddle (1956) 
B. neotomae Smooth Desert rat + Stoenner and Lackman (1957) 
B. canis Rough Dog + Carmichael and Bruner (1968) 
B. ceti (B. delphini) Smooth Dolphins + Foster et al. (2007) 
B. pinnipedialis (B. phocae) Smooth Seals + Foster et al. (2007) 
B. microti Smooth Wild voles (?) Scholz et al. (2008) 
B. inopinata Smooth Human ++ Scholz et al. (2008) 
B. papionis (?) Baboons (Papio spp.) (?) Whatmore et al. (2014) 
B. vulpis (?) Red foxes (Vulpes vulpes) (?) Scholz et al. (2016) 
N.N. Smooth Frog (?) Soler-Lloréns et al. (2016) 
(Adapted from El-sayed and Awad, 2018).
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1.2. Pathogenic Mechanism of Brucella 
In general, clinical infections of Brucella occur through mucosa and tissue along 
with various bacteria. Martirosyan et al. has summarized the process of Brucella 
infection as follows. First, Brucella has to be strong and protect his being. Second, 
Brucella should adapt to host cells without causing a distraction and release host 
damage materials while avoiding colliding with self-protection. Finally, Brucella has 
to give up, convert, or hide molecular patterns related to pathogens, except that they 
conflict with the first or second law [Martirosyan et al., 2011]. Thus, Brucella can 
survive and replicate within the host through this process. 
Brucella is involved in many factors to stably parasitize the host cell while 
protecting itself in the invasion process. In particular, Brucella has excellent 
resistance ability to many bactericidal substances generated to counter external 
bacterial infection within the host [Martinez de Tejada et al., 1995; Freer et al., 1996; 
Paramo et al., 1998; Manterola et al., 2007; Ettema et al., 2009]. This property is 
related to the structure of cell membranes with high hydrophobicity. Specifically, 
Brucella's outer membrane is composed of phospholipids, ornithine lipids, 
lipoproteins, and non-canonical lipopolysaccharide (LPS) molecules. Lipid A and 
core oligosaccharides of Brucella LPS (Br-LPS) reduce the number of negatively 
charged sugars [Conde-Á lvarez et al., 2013]. These features help to reduce negative 
charge on smooth bacterial surfaces overall [Conde-Á lvarez et al., 2013]. As a result, 
Brucella does not bind complement, microbicidal defensins, bactenecins, 
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cathelicidins, or any other cationic bactericidal molecule. This particular cell 
envelope structure makes Brucella highly resistant to all highly active molecules for 
pathogenic bacteria such as complement lysozyme, phospholipases, and lactoferrin, 
as well as most germicidal materials containing lysosomal extracts (Figure 1). As a 
result of separating Br-LPS having this role from Brucella, isolated Br-LPS almost 
did not bind complement [Barquero-Calvo et al., 2007; Barquero-Calvo et al., 2009]. 
In addition, Brucella mutants deficient in O-chain with core defects or lipid A 
imbalance are more susceptible to bactericidal substances and complement. 
Brucella should avoid the fusion of the Brucella-containing vacuole (BCV) with 
the host cell lysosomes, thereby protecting and moving to a place where it can 
replicate itself. To do this, several processes of the cells must be destroyed. For the 
first few minutes after penetration into the non-professional phagocyte, both the 
virulent Brucella and the attenuated vaccine strain (B. abortus 19) also interact with 
the early endosomal compartments. This was confirmed by expression of the early 
endosomal markers, transferrin receptor, GTP-binding protein rab5, or early 
endosomal antigen in early BCVs [Pizarro-Cerdá et al., 1998; Delrue et al., 2001]. 
In addition, this phenomenon becomes to decrease after 10 minutes of infection. 
Nevertheless, acidification of the BCV compartment is needed early in the 
maturation of BCV [Porte et al., 1999] and acquisition and maintenance of LAMP-
1 (lysosomal-associated membrane protein-1) are required for 4 h after infection. 
Simultaneously as LAMP-1 decreases, BCVs acquire an ER marker (glucose 6-
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phosphatase) such as calreticulin or calnexin. Through this process, B. abortus 
moves to a safe place (Figure 2) [de Figueiredo et al., 2015]. 
In the intracellular replication of B. abortus in the early stages of infection, small 
GTPase Sar1 is present as an important protein in the presence of ER membrane and 
perfusion towards Golgi [Stephens et al., 2000; Barlowe et al., 2002; Celli et al., 
2005]. In addition, the ER membrane contains not only ER Chaperone (calnexin, 
calreticulin, the translocator sec61β and an ER-resident enzyme protein disulfide 
isomerase (PDI)) for replication of B. abortus [Pizarro-Cerdá et al., 1998; Pizarro-
Cerdá et al., 1999; Comerci et al., 2001; Celli et al., 2005], but also two non-ER 
related cell proteins (GAPDH and GTPase Rab2), which are essential for the survival 
of B. abortus (Figure 3) [Fugier et al., 2009].  
Several factors are involved in intracellular trafficking and survival of Brucella 
[Gomez et al., 2013]. However, the exact control mechanism for these is still 
unknown. One well-known element is the Type-4-secretion system (T4SS), which is 
encrypted in the VirB region [O'Callaghan et al., 1999; Celli et al., 2003]. This 
region consists of 12 genes that form the operon [Porte et al., 1999]. Although VirB-
deficient mutants have the same cell penetration rate as wild Brucella [Celli et al., 
2003; Fontes et al., 2005], it does not promote BCV and ER fusion then fuses with 
the lysosome [Arellano-Reynoso et al., 2005]. Nonetheless, when infected the wild 
Brucella and the mutant at the same time, the mutant can move to the replication 
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niche. This suggests that the VirB system is necessary for trafficking but is not an 
essential factor for late replication. 
Cyclic β-1,2-glucan (cβG) acts as an osmotic pressure regulator as another factor 
controlling Brucella trafficking [Arellano-Reynoso et al., 2005]. cβG has a structure 
similar to β-cyclodextrin. β-cyclodextrin shows a high affinity with cholesterol 
present in the cell membrane and allows cell lysis through the destruction of the lipid 
structure. On the other hand, cβG exhibits a low affinity for cholesterol. And it can 
migrate lipid structure, but do not have any toxicity or dissolution in cells. In addition, 
cβG is not transported by the VirB system, and this polysaccharide is not present in 
the outer membrane fraction shed by Brucella [Aragón et al., 1996]. One of the 
important systems involved in the intracellular survival of Brucella is Brucella 
virulence-related regulatory (BvrR) and sensory (BvrS), two component regulation 
systems very similar to the putative system present in the animal pathogen 
Bartonella henselae [Quebatte et al., 2010]. Both BvrR and BvrS mutants are less 
invasive than wild-type strains and both mutants are not replicated in phagocytes or 
non-phagocytes and are targeted to lysosomes for degradation [Sola-Landa et al., 
1998]. Moreover, the BvrR/BvrS mutant cannot directly activate the Cdc42 small 
GTPase upon cell contact and remains bound to the host cell surface without the 
ability to penetrate the cell. These events indicate that these two component systems 
regulate the expression of molecular determinants required for invasion [Guzmán-
Verri et al., 2001]. It has also been shown that the BvrR regulatory protein directly 
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interacts with and regulates the promoter region of the VirB operon, and the 
expression of the transcriptional activator VjbR, which affects the VirB operon, is 
mediated by the regulatory action of the BvrS/BvrR system [Delrue et al., 2005]. 
This property demonstrates that BvrS/BvrS controls the expression of several 
systems essential for intracellular migration through direct and indirect mechanisms. 
Besides this, bacA gene [LeVier et al., 2000], cydB gene [Endly et al., 2001], purE 
gene [Crawford et al., 1996], aroC gene [Foulongne et al., 2001], Heat shock 
proteins and Cu-Zn superoxide dismutase (SOD) [Teixeira-Gomes et al., 2000] have 
been known factors to influence the pathogenesis of Brucella. 
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Figure 1. Schematic representation of Brucella cell envelopes and molecules 
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Figure 2. Working model of Brucella intracellular trafficking in macrophage cells. 
(Adapted from de Figueiredo et al., 2015). 
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Figure 3. Brucella invasion and intracellular trafficking in host mammalian cells. 
(Adapted from Gomez et al., 2013). 
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Ⅱ. BRUCELLA IMMUNE RESPONSES 
 
Brucella has the ability to evade immune responses in cells by developing 
a well-organized strategy that can interfere with the innate immune 
recognition that ultimately prefers the environment to evolve and adaptive 
immune responses to host cells after infection [Diacovich and Gorvel, 2010]. 
In particular, antibodies of the IgG, IgM or IgA class play a role in defending 
the host from brucellosis. Anti-Brucella antibodies are proteins that cause 
aggregation, complement fixation, and precipitation when they react with 
homologous antigens from Brucella. Most reactive antibodies were induced 
by Brucella lipopolysaccharide (Br-LPS) rather than cytoplasmic protein. 
The IgM antibody to Br-LPS appears for the first time after infection and 
gradually increases in the course of acute infection whereas the IgG antibody 
appears later in the Brucella infection and is caused by the Brucella 
cytoplasmic protein. Therefore, based on this, most of the sera can be used to 
distinguish host infections based on LPS. Cytoplasmic proteins do not have a 
single antigenic determinant that distinguishes between infected human and 
naturally infected animals. Therefore, the identification of important 
antigenic determinants among strains of Brucella spp. or the discovery of 
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suitable substances that do not cross-react with other bacteria is important for 
the diagnosis of brucellosis, and such studies have been still undergoing. 
 
2.1. Innate Immune Response 
The first lines of defense against Brucella are the phagocytosis by cells 
(neutrophils, macrophages, dendritic cells (DC), natural killer (NK) cells), secretion 
by cytokines and chemokines, and by the typical molecular recognition of pattern 
recognition receptors (PRRs) in microbes, pathogen-associated molecular patterns 
(PAMPs) and complement systems [Diacovich and Gorvel, 2010]. Neutrophils are 
one of the most important phagocytic cells in the innate immune response to 
microbial pathogens. This is the first immune-related cell encountered in host cell 
infection of Brucella. In brucellosis, however, these cells are not stimulated for 
effective degranulation. For example, B. abortus inhibits the myeloperoxidase H2O2-
halide antimicrobial system in bovine neutrophils by releasing GMP and adenine and 
inhibiting degranulation [Canning et al., 1985]. Although this pathogen is not 
replicated in neutrophil cells, it can survive in the early stages of infection and resist 
death [Barquero-Calvo et al., 2007].  
In addition to neutrophils, there are activated NK cells that act as the first line of 
defense against Brucella and killing infected targets [Fernandes et al., 1995]. 
Brucella activates NK cells by inducing interleukin-2 (IL-2)-releasing antigen-
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presenting cells and it converts NK cells into killer cells by IL-2 activation, IFN-γ 
secretion, and production, which play an important role in Th1 or Tcl expression 
[Gao et al., 2011]. In human NK cells, the cytotoxicity was increased when NK cells 
were treated with interleukin-12 (IL-12) obtained from a macrophage stimulated 
with heat killed B. abortus in vitro. It suggests that NK cells are a more potent role 
in human brucellosis [Zaitseva et al., 1996]. On the other hand, the role of NK cells 
in mouse brucellosis is not much critical [Fernandes et al., 1995].  
Macrophages and dendritic cells are considered to be a key component of the 
innate immune response to intracellular bacteria such as Brucella. Within hours of 
invading into host cells, a few pathogens reach replication available niche during 80-
90% of pathogens are killed by macrophages and dendritic cells [Watarai et al., 
2002]. In a bactericide function in macrophage, reactive oxygen intermediates (ROIs) 
and reactive nitrogen intermediates (RNIs) induced by gamma interferon (IFN-γ) 
and tumor necrosis factor (TNF-α) play an important role [Jiang et al., 1993]. In 
addition, for Interferon (IFN) signaling, the second transcription factor, IFN 
regulatory factors (IRFs) mediate various phenotypes induced by IFN. Expression 
of IRF-1, IRF-2, and ICSBP among IRFs is induced by IFN-γ, and IRF-1- and 
ICSBP-deficient mice are susceptible to B. abortus when ROI and RNI were 
absented [Ko et al., 2002]. 
Lipid A, which plays an important role in immune evasion through TLR4, was 
produced in Brucella. Brucella contains a longer fatty acid residue (C28) compared 
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to other intestinal bacterial LPS (C12-C16). It reduces endotoxicity by reducing TLR4 
antagonism due to this alteration of the LPS structure [Lapaque et al. 2009]. B. 
abortus mutants lacking lipid A with the C28 acyl chain have greater inflammatory 
status than wild-type strains. It has also decreased infectivity in BALB/c mice and 
macrophages [Parent et al., 2007]. 
Brucella can suppress innate immune signals by producing PAMPs with 
decreased TLR agonist activity through TIR domain-containing proteins, Btp1 in B. 
abortus and TcpB in B. melitensis. However, although the detailed mechanism of 
this protein has not been fully elucidated, TIR domain-containing protein TcpB is 
known to inhibit TLR signaling through interaction with adapter proteins 
TIRAP/Mal and MyD88 in host cells [Snyder et al., 2014]. 
Br-LPS, a stealth invader, plays a crucial role in reducing the deposition of 
complement component C3 [Barquero-Calvo et al., 2007]. C3 is covalently bound 
to the hydroxyl moiety present on the surface of the bacteria. The production of pro-
inflammatory complement products such as C3a and C5a is prevented by C3 binding 
to the Brucella O-antigen. Previous study has shown that O-antigens play an 
important role in promoting non-inflammatory responses through lipid raft 
microdomains and macrophage class A scavenger receptors SR-A [Kim et al., 2004]. 
These studies of innate immunology of Brucella imply that the key strategy that 
Brucella uses to regulate innate immune mechanisms is the inhibition to TLRs, the 
complement system and phagocytic cells such as macrophage, DC, and NK cell etc 
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[Dorneles et al, 2015]. Therefore, it is necessary to study the precise mechanism of 
action of these innate immune responses and the complex immune responses that 
occur in the in vivo system. 
 
2.2. Adaptive Immune Response 
Even if innate immunity effectively controls the replication of Brucella in the 
acute phase of infection, an adaptive immune response is an essential mechanism in 
the chronic phase [Baldwin and Goenka, 2006]. Moreover, adaptive immune 
responses are important for providing memory function, a key element of 
immunization when pathogens invaded again. Brucella developed several strategies 
to avoid host defense mechanisms and establish chronic infections [Ahmed et al., 
2016]. First, IFN-γ produced by CD4+, CD8+, and T cells activates bactericidal 
functions in macrophages to interfere with the cellular survival of Brucella. Second, 
infected macrophages were killed due to the cytotoxicity of CD8+ and T cells. 
Finally, Th1 type antibody isotype such as IgG2a and IgG3 promotes phagocytosis 
by opsonizing of pathogens. In brucellosis, these three mechanisms are well known 
for adaptive immune responses. In addition, cytokine expression such as IL-12, IFN-
γ, and TNF-α induces not only innate and adaptive immune responses between 
Brucella and host cells but also regulates the activity and/or action of immune-
related cells [Martirosyan et al., 2011; Durward et al., 2012]. Br-LPS successfully 
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elevates Th1 type cytokine responses such as IL-10 and IFN-γ [Kianmehr et al., 2015] 
in Brucella infection of macrophages during controlling the expression of IL-12, 
especially [Fahel et al., 2015]. In Brucella infection, cytokines not only control 
innate and adaptive immune responses but also play an important role in directly 
among immune-related cells in the host. IL-12 is a major factor produced by B cells 
and macrophage and is lead in inducing the Th1 response, eventually expressing 
IFN-γ in host T cells. In addition to IL-12, there are other cytokines involved in 
adaptive immune responses and it was studying as important through differences in 
the amount of expression given by different pathogens. [Pizarro-Cerdá et al., 1999; 
Hielpos et al., 2018]. 
Some cells such as DCs play an important role in the initiation and regulation of 
these adaptive immune responses [Kapsenberg, 2003]. To avoid the function of these 
cells, intracellular pathogens established several mechanisms. In particular, Brucella 
has established several strategies for confirming the transition from the innate 
immune system to the adaptive immune system for avoidance of the host immune 
system. Recently, some evidence has confirmed the efficient propagation of this 
pathogen in DCs in vitro [Archambaud et al., 2010] and in vivo [Salcedo et al., 2008]. 
It indicates that Brucella can prevent the development of a protective Th1 immune 
response by avoiding the induction of IL-12 and T cell stimulating the activity of 
infected DCs [Salcedo et al., 2008]. In addition, the ability of the Brucella-infected 
DC to mature and express MHC class II, which represents a specific T cell, for an 
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exogenous protein antigen is decreased [Salcedo et al., 2008; Billard et al., 2007; 
Gomez et al., 2013]. Therefore, studies of the immune mechanism in Brucella 
infection need to accurately identify of Brucella feature when they invade to the host, 
time-dependent manner. Furthermore, there is a need to continuously study the 
method of blocking Brucella more effectively at the early stage of infection and 
intracellular survive and replicate stages (Figure 4). 
 




Figure 4. The key mechanisms in different cells of the innate and adaptive immune system after B. abortus infection. 
(Adapted from Dorneles et al., 2015).
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Ⅲ. CURRENT IMMUNOLOGICAL STUDIES OF BRUCELLA 
 
Brucellosis has continuously emerged and it is a zoonosis caused economic loss 
and social issue. However, the treatment methods that are suitable to the patient, or 
effective vaccines have not been universalized until now. In contrast, Brucella has a 
remarkable strategy of avoiding host immune responses and promoting the formation 
of chronic infections. Therefore, host cells have developed complex immune 
mechanisms to survive against pathogens with this ability. 
During intracellular replication, Brucella exhibits typical tissue affinities in lymph 
nodes and reproductive organs, helping to avoid inherent adaptive immune 
mechanisms in the host to establish clinical disease manifestations and pathogenesis. 
Symptoms in the early stages of Brucella infection observed in humans are fatigue, 
fever, anorexia, myalgia, and sweating. And the mononuclear phagocytic system, 
including bone marrow, lymph nodes, liver, and spleen, is continuously observed in 
the chronic stage. In the early stage of Brucella infection, it modulates the host 
immune response mechanism to rapidly migrate the mucosal immune barrier and 
form endocytosis by mucosal macrophages and DCs. Brucella protects itself by 
infecting host cells and limiting the role of PRR, including the complement system 
and TLR signaling pathways. In addition, Br-LPS exhibits non-canonical structural 
differences that inhibit antigen presentation to T cells and attenuate innate and 
adaptive immune mechanisms. Specifically, Br-LPS inhibits the activation of DC to 
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establish a defensive Th1 immune response by preventing T-cell stimulation, which 
releases IL-12 through destroying the immune response. Brucella also regulates 
MHC-I and MHC-II expression promoted by IFN-γ dependent on cytokine 
regulation. In addition, Brucella has a variety of survival strategies such as inhibiting 
apoptosis, avoiding immune responses and establishing chronic infections (Figure 
5).  
Recently, studies on intracellular survival and replication and immune responses 
of the Brucella are steadily investigating. One of a candidate in Brucella substances 
is that Brucella recombinant proteins which have been continuously using for 
developing Brucella vaccine and analysis of immune responses within the host. In 
recent years, many studies have been actively conducted to examine the possibility 
of identifying novel Brucella antigens as candidates for the development of vaccines 
and effective immune responses in host cells using Brucella cellular proteins 
including outer membrane proteins such as Mdh, TbpA, RocF, OMP10, and OMP19 
[Lim et al., 2012b; Simborio et al., 2015; Im et al., 2017; Im et al., 2018]. In addition, 
it was reported as a possible candidate substance for Brucella diagnosis by analyzing 
changes in immune response or gene expression in different hosts stimulated with 
Brucella recombinant protein or through changes in immune responses by mucosal 
immunization with Brucella recombinant protein nanoparticle. [Im et al., 2016a; Im 
et al., 2018b; Soh et al., 2019]. In addition, vaccine candidate research using 
Brucella mutants [Bao et al., 2017; Zhang et al., 2017; Li et al., 2017; Li et al., 2018] 
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and study about small RNA role in Brucella infection are active [Eskra et al., 2003; 
Xu et al., 2018]. Particularly, identifying the role of microRNAs in autophagy and 
apoptosis in the cellular survival of Brucella will be a part of understanding the 
immune mechanism of Brucella infection. Ultimately, the study of immune 
responses in brucellosis is still the biggest challenge in the field of studying Brucella, 
as well as a task to be solved. 
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Figure 5. Strategies of Brucella to evade the innate and adaptive immunity. 
(Adapted from Ahmed et al., 2016). 
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Chapter I 
 
Expression of Cytokine and Apoptosis-related Genes 
in Bovine Peripheral Blood Mononuclear Cells 




Brucellosis is a clinically and economically important disease. Therefore, 
eradication programs of the disease have been implemented in several countries. One 
hurdle in these programs is the detection of infected animals at the early stage. 
Although the protein antigens as diagnostic antigens have recently received attention, 
the exact mechanisms at the beginning of immune responses are not yet known. 
Therefore, genes encoding five Brucella abortus cellular antigens were cloned and 
the expressed recombinant proteins were purified. The expression of several 
cytokine genes (IL‑1β, IL‑4, IL‑6, IL‑12p40, IFN‑γ, TNF‑α, and iNOS) was 
analyzed in bovine peripheral blood mononuclear cells (bPBMC) after stimulation 
with B. abortus antigens. Three apoptosis‑related genes, Bax, Bcl‑2, and TLR4, were 
also included in the analysis to find out the adverse effects of the proteins to the cells. 
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Each protein induced different patterns of cytokine expression depending on the 
stimulation time and antigen dose. Expression of IL‑6, IL‑12p40, and IFN‑γ was 
induced with all of the proteins while IL‑1β, IL‑4, TNF‑α, and iNOS gene expression 
was not. Expression of apoptosis‑related genes was not altered except TLR4. These 
results suggest that the cellular antigens of B. abortus induce both humoral and 
cellular immunity via the production of IL‑6, IL‑12p40, and IFN‑γ in bPBMC 
without exerting any adverse effects on the cells. 
 
Key words: Brucellosis, Brucella abortus cellular antigen, Cytokines, bovine 
Peripheral mononuclear cell, Apoptosis-related gene. 
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Introduction 
 
Brucellosis is a highly contagious zoonosis caused by Gram-negative bacteria of 
the genus Brucella. This disease affects livestock, wild animals, and humans. Ten 
species of the genus Brucella have been identified based on antigen variation and 
primary hosts [Corbel, 1997; Sung and Yoo, 2014]. Brucellosis causes significant 
economic losses not only because it affects animal production (reduced milk 
production, abortion, delayed conception, and impaired fertility) but also because 
detection of the disease in a region or country causes enactment of international 
veterinary regulations as well as restrictions on animal movements and trade [Corbel, 
1997; Seleem et al., 2010]. In addition, brucellosis in human can be severely 
debilitating and remains an important public health concern [Corbel, 1997; Young, 
1995].  
Most serological diagnostic methods for detecting Brucella infection use 
antibodies against common Brucella antigens [Nielsen and Yu, 2010]. O-
polysaccharide (OPS), a well-known immune dominant epitope in smooth 
lipopolysaccharide (SLPS), is commonly used in serological tests for diagnosing 
brucellosis [Moreno et al., 1984; Jiménez de Bagüés et al., 1992; Gall et al., 2008; 
McGiven, 2013]. Recently, several cellular proteins of B. abortus have been 
considered new diagnostic antigens because traditional diagnostic methods using 
Brucella LPS have low specificity due to cross-reactivity with other relevant bacteria 
such as Yersinia enterocolitica O:9 [Corbel, 1979; Nielsen et al., 2004].  
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Brucella abortus is a facultative intracellular bacterial pathogen that can survive 
intracellular defenses and hamper the induction of host humoral immune responses 
[Cheers, 1984]. These properties help preventing the serological diagnosis of B. 
abortus infection. Infection with B. abortus potently activates both the innate and 
adaptive immune system, leading to a proinflammatory response that favors the T-
helper 1 (Th1) responses [Dornand et al., 2002; Golding et al., 2001]. Although both 
antibody- and cell-mediated immune responses can influence the course of Brucella 
infection, the latter is primarily responsible for the clearance of intracellular bacteria 
[Li et al., 2014].  
Brucella spp. have mechanism that prevent activation of the host innate immune 
system [Barquero‑Calvo et al., 2007]. Invasion through the digestive tract does not 
elicit any inflammatory response including cytokine production from the host 
[Paixao et al., 2009]. Therefore, Brucella spp. invade silently or unnoticed by the 
innate immune system of the host [Poester et al., 2013].  
Cytokines are important for responses to infection. Much attention has thus been 
given to research on cytokine-mediated inflammatory reactions in cases of 
brucellosis. Previous studies have revealed that B. abortus can induce the production 
of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin 
(IL)-6, IL-12 and IL-1β by a variety of cell types and in mice [Zhan et al., 1993; 
Zhan and Cheers,1995; Zaitseva et al., 1996; Huang et al., 2003; Cha et al., 2010].  
Understanding immune mechanisms is an important step for the development of 
new control measures including diagnostic antigen(s) since most of the antigens have 
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been selected based on reaction with antibodies without considering the immune 
responses in the host [Ko et al., 2012; Kim et al., 2014; Lee et al., 2014; Lee et al., 
2015]. However, the precious mechanisms of B. abortus infection including the 
possible apoptotic activities have not been revealed in the expression of cytokines 
and apoptosis-related genes, yet. Therefore, to understand the mechanism underlying 
the immune responses to B. abortus, bovine peripheral blood mononuclear cells 
(bPBMC) were treated with five well-known immunoreactive B. abortus cellular 
proteins. Cytokine production and the expression of genes associated with apoptosis 




Materials and Methods 
 
Cloning and expression of B. abortus genes 
Genes encoding outer membrane protein 28 (OMP28), malate dehydrogenase 
(Mdh), elongation factor Ts (Tsf), arginase (RocF), and metal-dependent hydrolase 
(0628) of B. abortus 544 were amplified by PCR (Table 2), cloned, and expressed 
with a cold shock expression vector (pColdTM TF DNA; Takara, Japan) in E. coli 
DH5α. Sequences of the primers used for this procedure are shown in Table 2. 
Nucleotide sequences of the genes were confirmed by sequencing using an automatic 
sequencer and dye-termination sequencing system. 
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Purification of the recombinant proteins  
Five E. coli clones were cultured at 37 °C overnight in 100 ml of LB broth 
(Duchefa Biochemie, The Netherlands) with 10 μg of ampicillin (Duchefa 
Biochemie, The Netherlands). Sixty ml of the cultures were used to inoculate 1 liter 
of LB broth containing 100 μg of ampicillin. After culturing with shaking at 220 rpm 
for 3 h at 37 °C, isopropyl β-D-1-thiogalactopyranoside (IPTG; Amresco, USA) was 
added at a final concentration of 0.5 mM and the culture was further incubated 
overnight at 37 °C in a shaking incubator (Vision Science Co. Ltd., Korea) at 
220 rpm. After incubation, the bacterial cells were harvested by centrifugation at 
4400 x g for 20 min. The resulting pellets were resuspended in 40 mL of binding 
buffer (20 mM Tris–HCl, 8 M urea, 500 mM NaCl, 20 mM imidazole (Sigma, USA) 
[pH 8.0], and 1 mM β-mercaptoethanol (Sigma, USA) and sonicated at 10 000 Hz in 
ice water (60 % pulse, 20 s pulse/50 s steps, 15 cycles). Supernatants were collected 
after centrifugation at 4,400 x g for 20 min. Recombinant proteins were collected 
using a His-Spin Trap (GE Healthcare, UK) according to the manufacturer’s protocol. 
Concentration of the purified recombinant proteins was measured using a BCA kit 
(Bio-Rad, USA). The recombinant proteins were analyzed by SDS-PAGE and 
Western blotting with an anti-His antibody (April Bio Co. Ltd., Korea). LPS 
contamination in the purified proteins was confirmed by endotoxin assay kit (Toxin 
SensorTM Chromogenic LAL endotoxin Assay Kit, GenScript). 
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bPBMC isolation and culturing 
Blood was collected into conical tubes (Nunc, USA) containing heparin from the 
jugular vein of clinically healthy Korean native cattle. The cattle were naïve to B. 
abortus exposure. The blood was overlaid onto 15 ml of Histopaque 1077 (Sigma, 
USA) in a 50 ml conical tube and centrifuged 400 x g for 30 min. Next, bPBMC 
were collected and washed three times with RPMI 1640 medium (Gibco, USA) 
containing 10 % fetal bovine serum (Gibco, USA). The bPBMC concentration was 
adjusted to 5 x 106 cells/ml and the cells were cultured in a 6-well plate with RPMI 
1640 medium containing 10 % FBS for 8 h at 37 °C in a 5 % CO2 atmosphere. After 
incubation, the bPBMC were stimulated with 5 or 10 μg/ml of the five different 
recombinant proteins for the indicated time intervals in the figures. LPS was 
removed by treatment with polymyxin B (10 μg/ml) before stimulation with the 
proteins. Concanavalin A (ConA, 1 μg/ml) was used as a positive control. All animal 
procedures were carried out according to the guidelines of the Institutional Animal 
Care and Use Committee (IACUC) of the Animal and Plant Quarantine Agency 
(South Korea). The study protocol was approved by the Seoul National University 
Institutional Animal Care and Use Committee (SNUIACUC: SNU-130916-3). 
 
Purification of total RNA from bPBMC  
Total RNA was isolated from the bPBMC using an RNeasy mini kit (Qiagen, 
Germany) according to the manufacturer’s protocol. Before reverse transcription of 
the RNA using a QuantiTect®  Reverse Transcription Kit (Qiagen, Germany) was 
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performed, genomic DNA was eliminated with 2 μl of gDNA wipeout buffer (7X), 
11 μl of RNase-free water, and 1 μg of template RNA. After incubating the mixture 
at 42 °C for 2 min, reverse transcription was carried out with 1 μl of quantiscript 
reverse transcriptase, 4 μl of quantiscript RT buffer (5X), 1 μl of reverse 
transcription primer mix, and 14 μl of cDNA generated by incubation at 42 °C for 
15 min. Quantiscript reverse transcriptase was inactivated by incubation at 95 °C for 
15 min. The reaction products were used to analyze gene expression with real-time 
PCR. 
 
Analysis of cytokine and apoptosis‑associated genes by real‑time PCR 
Real-time PCR was carried out using the cDNA products after completing reverse 
transcription-PCR. A Rotor-Gene SYBR Green PCR Kit (Qiagen, Germany) was 
used with a two-step cycling protocol including denaturation at 95 °C and a 
combined annealing/extension step dependent upon the primer Tm value according 
to the manufacturer’s protocol. The reaction mixture contained 10 μl of 2X Rotor-
Gene SYBR Green PCR Master Mix, 2 μl of the primers, 2 μl of template DNA or 
cDNA, and 6 μl of RNase-free water. The real-time PCR conditions were as follows: 
initial denaturation at 95 °C for 5 min followed by 50 cycles of 95 °C for 20 s and 
annealing at 55 °C or 60 °C for 10 s. The expression of each gene was normalized 
relative to the expression of β-actin. Genes encoding inducible nitric oxide synthase 
(iNOS), IL-1β, IL-4, IL-6, IL-12p40, interferon (IFN)-γ, and TNF-α were analyzed. 
Three apoptosis-related genes, Bcl-2-associated X protein (Bax), B cell lymphoma 
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2 (Bcl-2), and Toll-like receptor-4 (TLR4), were also analyzed. Sequences of the 
primers and probes used in this real-time PCR are presented in Table 3. 
 
Statistical analysis 
Data are reported as the mean ± standard error of the mean (SEM) of three or more 
independent experiments. Statistically significant was determined by the Student t 
test using statistical package for social science (SPSS) software version 21. 





Genes encoding five different cellular proteins of B. abortus (rOMP28, rMdh, rTsf, 
rRocF, and r0628) were cloned, sequenced, and expressed in E. coli. The expressed 
proteins were purified and analyzed by SDS-PAGE and Western blotting using an 
anti-His antibody (Figure 6). As a result of LPS contamination, treatment of PBMC 
with each B. abortus antigens showed 0.01 EU/ml (measurement range 0.01 - 1 
EU/ml), and the intracellular effects due to LPS contamination were negligible after 
confirmed the number of endotoxin unit. Generally, treatment with each recombinant 
protein induced different patterns of cytokine expression depending on stimulation 
time and dose. However, the expression of apoptosis-related genes was not greatly 
affected by stimulation with B. abortus antigens. Induction of iNOS gene expression 
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was up-regulated at 12 or 24 h after stimulation of bPBMC with 10 μg of rOMP28, 
rMdh, rTsf, and rRocF proteins (P < 0.01) while there was no significant change in 
the gene expression with 5 μg of all B. abortus antigens (Figure 7). IL-1β gene 
expression was significantly down-regulated dose and time-dependently after 
stimulation with 5 μg and 10 μg of all B. abortus antigens in the cells (P < 0.05) 
(Figure 8). In case of IL-4, induction of significant gene expression was observed in 
the bPBMC stimulated with only 5 μg of rRocF protein (P < 0.05) even though 10 μg 
of rTsf and r0628 proteins induced the gene expression in the cells (Figure 9). 
Expression of IL-6 gene was highly induced time and dose-dependently with all B. 
abortus antigens (P < 0.01) (Figure 10). rMdh and rRocF were the most effective 
inducers in the IL-6 gene expression in the bPBMC (P < 0.01). Also, 10 μg of rTsf 
induced the higher gene expression of IL-6 at 12 h after the stimulation (P < 0.01). 
Induction of IL-12p40 gene expression was the most effective when the cells were 
stimulated with 5 μg of all B. abortus antigens for 12 h (P < 0.01) (Figure 11). The 
induction was also effective with 10 μg of rOMP28 and r0628 proteins at 12 and/or 
24 h after the stimulation (P < 0.01). IFN-γ gene expression was significantly 
induced in the cells stimulated with 5 μg of all B. abortus antigens for 12 h (P < 0.01) 
even though the significant induction was also observed with 10 μg of rOMP28 and 
r0628 proteins (P < 0.01) (Figure 12). After stimulation of the cells with 10 μg of all 
B. abortus antigens, TNF-α gene expression was significantly induced at 12 and/or 
24 h (P < 0.01). Five μg of B. abortus antigens could not induce the TNF-α gene 
expression except at 24 h with rTsf protein (Figure 13).  
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In apoptosis related gene expression, Bax, Bcl-2 and TLR4, the gene expression 
was mostly down-regulated in the cells stimulated with 5 μg of all B. abortus 
antigens even though 10 μg of some B. abortus antigens induced the gene expression 
at different times (Figures 14, 15, 16). The gene expression of Bax was down-
regulated with 5 μg of B. abortus antigens (P < 0.05) while 10 μg of rOMP28, rRocF 
and r0628 proteins up-regulated the gene expression (P < 0.05) (Figure 14). 
However, the changes might not be effective even though there was significant 
difference. Bcl-2 gene expression was effectively up-regulated with 10 μg of rMdh 
in 24 h stimulation (P < 0.01). There were no meaningful changes in the gene 
expression of Bcl-2 (Figure 15). TLR4 gene expression was significantly down-
regulated when the cells stimulated with 5 μg of all B. abortus antigens (P < 0.05) 
while 10 μg of rMdh and rRocF proteins induced higher gene expression of TLR4 
(P < 0.05) (Figure 16). 
In summary, the production of iNOS, IL-4 and TNF-α was not effectively induced 
in bPBMC by stimulation with B. abortus antigens even though some induction was 
observed at certain times by treatment with 10 μg of rOMP28, rTsf, and rRocF. IL-
1β gene expression was down-regulated in dose and time-dependent manner in the 
stimulation of cells with all B. abortus antigens. IL-6, IL-12p40 and IFN-γ gene 
expression was effectively induced in the cells stimulated with all B. abortus 
antigens, especially 5 μg of B. abortus antigens. The expression of a gene associated 
with apoptosis in bPBMC was not induced by exposure to 5 μg of the B. abortus 
antigens. However, expression of the apoptotic genes was induced with different 
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Brucellosis is a re-emerging zoonosis that has regained attention of the scientific 
community because pathogenesis of this disease in humans and animals has 
significantly evolved [Seleem et al., 2010; Pappas, 2010]. However, the overall 
burden of the disease remains underestimated and has not been well studied. 
Eradication of brucellosis in animals is important for prevention of this disease in 
humans and requires optimal diagnosis along with vaccination [McGiven et al., 
2006]. The cellular proteins of B. abortus have received increased attention in the 
development of diagnostic techniques and vaccines given the important roles of these 
proteins in the early stage of infection [Cha et al., 2010]. In addition, the information 
will help to reveal mechanisms underlying the pathogenesis of Brucella infection. 
Brucella is able to infect macrophages, and persist and replicate in the intracellular 
environment [Hamer et al., 2014]. Identifying bacterial proteins that are necessary 
for intracellular survival of Brucella may provide new insights into mechanisms 
associated with pathogenesis and immune protection along with candidate antigens 
for diagnosis and vaccines [Goldbaum et al., 1993; Baldi et al., 1996; Ghasemi et 
al., 2014]. Although several immunogenic proteins of B. abortus have been 
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identified [Ko et al., 2012; Kim et al., 2014; Lee et al., 2014; Lee et al., 2015], roles 
of these proteins still remain unclear. Based on recently acquired knowledge, five 
different cellular proteins of B. abortus with unknown potential in the induction of 
immune responses were selected for analysis in this study and effects of B. abortus 
antigens on bPBMC were investigated.  
To evaluate the potential of five B. abortus antigens as diagnostic antigens, 
underlying mechanisms of the proteins in PBMC were investigated. Therefore, five 
genes were cloned, and the recombinant proteins were expressed and purified. After 
stimulation of bPBMC with B. abortus antigens, the expression of cytokines and 
apoptosis-related genes were analyzed by real-time reverse transcription-PCR. Most 
of the proteins induced the expression of IL-6, IL-12p40 and IFN-γ in a time- and 
dose-dependent manner. This result concurs with finding from a previous study 
showing that high amounts of IFN-γ, IL-12, and IL-6 are produced by splenocytes 
of mice vaccinated with chaperone protein DnaK [Ghasemi et al., 2014]. In vivo-
induced antigen technology (IVIAT) using elk (Cervus elaphus) revealed that Mdh 
is a predictor of natural infection [Lowry et al., 2010]. Mdh is commonly expressed 
during infection in cattle and elk, and is not only an immunogenic protein but also 
promotes bacterial pathogenesis as a new virulence factor [Lowry et al., 2010; Han 
et al., 2014]. These data are similar to our results showing the effect of Mdh on 
cytokine production. 
The B. abortus efp mutant has slower growth in complex media and higher 
sensitivity to detergents [Iannino et al., 2012]. The efp gene is also required for 
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internalization in nonprofessional macrophages and HeLa cells [Iannino et al., 2012]. 
However, the gene does not appear to be associated with virulence in professional 
macrophages, J774 macrophage-like cells, or mice [Iannino et al., 2012]. 
Immune responses rely to a great extent on the recognition of foreign antigens by 
toll-like receptors (TLR). These receptors detect different pathogen-associated 
molecular patterns (PAMP), and trigger the activation of myeloid differentiation 
primary response gene 88 (MyD88)- and TIR-domain-containing adaptor-inducing 
interferon-β (TRIF)-dependent signaling pathways. This in turn leads to a wide range 
of cellular responses including the secretion of proinflammatory cytokines, 
chemokines, and type I interferons [Kawai and Akira, 2010]. In this study, gene 
expression of TLR4 was down-regulated up to 24 h and up-regulated in the 
stimulation with B. abortus antigens. Previous studies on the TLR4 expression 
showed down-regulation of TLR4 expression up to 24 h and upregulation of the 
expression after 24 h in the macrophage cells stimulated B. abortus or LPS of the 
bacterium [Weiss et al., 2005; Nomura et al., 2000]. This phenomenon was similar 
with this study with bPBMC. 
These results suggest that B. abortus antigens might induce proper immune 
responses without adverse effects (such as apoptosis) in the bPBMC. Gene 
expression of iNOS, TNF-α, and IL-1β was not effective in the cells by stimulation 
with B. abortus antigens. On the contrary, gene expression of IL-6, IL-12p40, and 
IFN-γ was significantly increased with B. abortus antigens. These results indicate 
that the adaptive immune systems are effectively activated by B. abortus antigens in 
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bPBMC. In conclusion, the five B. abortus antigens examined in this study appear 
to induce effective adaptive immune responses in both humoral and cellular 
immunity without induction of inflammatory reaction. 
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Table 2. Primer sequences for cloning Brucella abortus genes 






Outer membrane protein 28 
(OMP28) 
F: GATCGGATCCAACACTCGTGCTAGCAATTTT 




















55 624 [Im et al., 2016a] 
R: AGCGCTGCAGTTAAGCTTGGAAGCTGTG 
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Table 3. The primer sets for real-time PCR 
















































60 227 [Konnai et al., 2003] 
R: TCCAAGGCGACGTAGCAGAG 
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Figure 6. Analysis of the purified recombinant proteins. SDS‑PAGE and Western 
blotting with an anti‑His antibody. Lane M: molecular weight markers (Life 
Technologies, USA), lane 1: Outer membrane protein 28 (OMP28) (88 kDa), lane 2: 
Malate dehydrogenase (Mdh) (91 kDa), lane 3: Elongation factor (Tsf) (93 kDa), 
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Figure 7. Gene expression of inducible nitric oxide synthase (iNOS) in bovine 
PBMC. Bovine PBMC were stimulated with 5 μg (A) and 10 μg (B) of five different 
cellular antigens (rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 
12, and 24 h. Gene expression was analyzed by real‑time quantitative RT‑PCR and 
normalized by the expression of β‑actin. (** P < 0.01). 
 - 45 - 
 
Figure 8. Gene expression of interleukin-1β (IL-1β) in bovine PBMC. Bovine 
PBMC were stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens 
(rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 9. Gene expression of interleukin-4 (IL-4) in bovine PBMC. Bovine PBMC 
were stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens 
(rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05). 
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Figure 10. Gene expression of interleukin-6 (IL-6) in bovine PBMC. Bovine PBMC 
were stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens 
(rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 11. Gene expression of interleukin-12p40 (IL-12p40) in bovine PBMC. 
Bovine PBMC were stimulated with 5 μg (A) and 10 μg (B) of five different cellular 
antigens (rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 
24 h. Gene expression was analyzed by real‑time quantitative RT‑PCR and 
normalized by the expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 12. Gene expression of interferon-γ (IFN-γ) in bovine PBMC. Bovine PBMC 
were stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens 
(rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 13. Gene expression of tumor necrosis factor-α (TNF-α) in bovine PBMC. 
Bovine PBMC were stimulated with 5 μg (A) and 10 μg (B) of five different cellular 
antigens (rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 
24 h. Gene expression was analyzed by real‑time quantitative RT‑PCR and 
normalized by the expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 14. Gene expression of Bax in bovine PBMC. Bovine PBMC were stimulated 
with 5 μg (A) and 10 μg (B) of five different cellular antigens (rOMP28, rMdh, rTsf, 
rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene expression was 
analyzed by real‑time quantitative RT‑PCR and normalized by the expression of 
β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 15. Gene expression of Bcl-2 in bovine PBMC. Bovine PBMC were 
stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens (rOMP28, 
rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Figure 16. Gene expression of Toll-like receptor 4 (TLR4) in bovine PBMC. Bovine 
PBMC were stimulated with 5 μg (A) and 10 μg (B) of five different cellular antigens 
(rOMP28, rMdh, rTsf, rRocF, and r0628) of Brucella abortus at 0, 12, and 24 h. Gene 
expression was analyzed by real‑time quantitative RT‑PCR and normalized by the 
expression of β‑actin. (* P < 0.05, ** P < 0.01). 
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Chapter Ⅱ 
 
Th2-related Immune Responses in in vitro and in 
vivo Stimulated with Brucella abortus Antigens, 
Malate dehydrogenase (Mdh), Elongation factor 




Brucellosis is an important zoonotic disease caused by Brucella species. The 
disease is difficult to control due to the intracellular survival of the bacterium and 
the lack of precise understanding of pathogenesis. Despite of continuous researches 
on the pathogenesis of Brucella spp. infection, there is still question on the 
pathogenesis, especially earlier immune response in the bacterial infection. 
Recombinant proteins, Malate dehydrogenase (rMdh), elongation factor (rTsf), and 
arginase (rRocF), which showed serological reactivity, were purified after gene 
cloning, and their immune modulating activities were then analyzed in a murine 
model. Cytokine production profiles were investigated by stimulating RAW 264.7 
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cells and naïve splenocytes with the three cellular antigens of Brucella abortus. Also, 
immune responses were analyzed by ELISA and an ELISpot assay after immunizing 
mice with the three proteins. Only TNF-α was produced in stimulated RAW 264.7 
cells, whereas Th1-related cytokines, IFN-γ and IL-2, were induced in naïve 
splenocytes. In contrast, Th2-type immune response was more strongly induced in 
antigen-secreting cells in the splenocytes obtained 28 days after immunizing mice 
with the three B. abortus antigens, as were IgM and IgG. The induction of Th2-
related antibody, IgG1, was higher than the Th1-related antibody, IgG2a, in 
immunized mice. These results suggest that the three B. abortus antigens strongly 
induce Th2-type immune response in vivo, even though Th1-related cytokines were 
produced in vitro. 
 
Keywords: Brucella abortus, antigens, Th1, Th2, Immune responses.
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Introduction 
 
Brucella spp. causes brucellosis, a major zoonotic disease, and is a facultative 
intracellular bacterium that might induce complicated immune responses. 
Brucellosis is considered as an important disease in both clinically and economically. 
Eleven species have been classified based on primary preferred host and antigenic 
variation : B. melitensis (sheep and goats), B. suis (hogs), B. abortus (cattle), B. ovis 
(sheep), B. canis (dogs), B. neotomae (wood rats), B. ceti (seals), B. pinnipedialis 
(pinnipeds), B. microti (common vole), B. inopinata (breast implant infection), and 
B. papionis (baboon) [Ko and Splitter, 2003; Foster et al., 2007; Scholz et al, 2010; 
Whatmore et al., 2014]. The intracellular survival and replication characteristics of 
Brucella spp. enable it to establish chronic infections in host cells [Detilleux et al., 
1990a; Detilleux et al., 1990b].  
B. abortus causes undulant fever, endocarditis, arthritis and osteomyelitis in man 
and abortion and infertility in cattle [Franco et al., 2007]. It easily infects animals by 
ingestion or inhalation bacterium in reproductive tissues, fetal fluids, and mammary 
gland. In man, brucellosis is usually transmitted by direct or indirect contact with 
abortion related discharges and ingestion of unpasteurized dairy products from the 
infected animals. To control brucellosis in man and cattle, it is considered the 
identification and removal of infected animals and/or vaccination have been used 
depending on infection status of countries.  
Lipopolysaccharide (LPS) has been considered to be the most important antigen 
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for the diagnosis of brucellosis although several other cellular antigens are involved 
in immune responses to the bacterium [Baldi et al., 1996]. Therefore, LPS-based 
antigens have been used for the serological confirmation of B. abortus infection in 
ruminants. Indirect diagnosis approaches are most widely used, such as, serological 
tests based on LPS, the standard tube agglutination test, the Rose Bengal plate 
agglutination test, the complement fixation test, and enzyme-linked immunosorbent 
assays. Although LPS elicits strong immune response, LPS-based diagnostic 
methods have several problems, such as, difficult differentiation of infected and 
vaccinated animals and cross-reactivity with various Gram-negative bacteria, like 
Yersinia enterocolitica O:9, Escherichia coli, Salmonella enterica serotype Urbana 
[Kittelberger et al., 1998; Oñate et al., 1999; Ruiz-Mesa et al., 2005; Nielsen et al., 
2007]. Therefore, many researchers have tried to develop non-LPS based diagnostic 
tools [Al Dahouk et al., 2006]. 
Recently, specific immune-reactive proteins of B. abortus were identified during 
proteomic analyses [Al Dahouk et al., 2006; Connolly et al.,2006; Ko et al., 2012; 
Lim et al., 2012a; Ghasemi et al., 2014]. Outer membrane proteins (OMPs) are 
considered major immunoreactive components of bacterial cells to develop new 
diagnostic or vaccine candidates [Cloeckaert et al., 1991; Chaudhuri et al., 2010; 
Ghasemi et al., 2014; Simborio et al., 2015], and many researchers working on the 
development of new diagnostic markers for brucellosis have studied other 
recombinant proteins of Brucella. In addition, immunodominant antigens have been 
investigated after immunization with Brucella spp. [Sung et al., 2014; Lee et al., 
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2015]. Most microorganisms have developed a transport and storage system to 
enhance survivability. In particular, iron is an essential element, and the role of 
bacterioferritin (Bfr) has been studied in the contexts of iron metabolism and survival 
in macrophages [Denoel et al., 1997]. Additionally, Lee et al. reported that the levels 
of expression some proteins, such as, malate dehydrogenase (Mdh), elongation factor 
(Tsf), and arginase (RocF), were correlated with the pathogenesis of Brucella 
infections and the metabolism of Brucella [Lee et al., 2015]. However, some 
mechanisms responsible for the immune responses of Brucella proteins have been 
studied but there are still insufficient about described immune mechanisms. To 
evaluate the induction of immunological responses after stimulation with three 
recombinant proteins, the production levels of T helper 1 (Th1)-related cytokines 
and T helper 2 (Th2)-related cytokines were measured. In addition, the induction of 
IgM, IgG1, G2a and total IgG were evaluated for determination of immune response 
types by measuring the number of antigen-secreting cells. In this study, three B. 
abortus antigens, Mdh, Tsf, and RocF, were investigated by examining production 
of cytokines and immune responses to cellular antigens of B. abortus in vitro and in 




Materials and Methods 
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Bacterial strains and construction of Mdh, Tsf and RocF expression clones 
Bacterial strains were cultured as previously described [Sung et al., 2014; Im et 
al., 2016b]. Total genomic DNA was prepared from B. abortus 544 culture using the 
G-spintm Genomic DNA Extraction kit for bacteria (Intron, Korea). Genes encoding 
Mdh, Tsf, and RocF of B. abortus were amplified by PCR using the primers pairs 
shown in Table 4. After digestion with appropriate restriction enzymes, amplified 
DNA was ligated into pCold TF vector (Takara, Japan). Ligated plasmids were then 
transformed into the E. coli DH5α host cells. Conservation of insert sequences in the 
expression vector was confirmed by nucleotide sequencing. 
 
Expression and purification of rMdh, rTsf and rRocF proteins  
The expression and purification of recombinant proteins were modified as 
previously described [Sung et al., 2014; Im et al., 2016b]. In brief, 20 ml of overnight 
cultured E. coli harboring plasmids was inoculated into one liter of LB broth 
containing ampicillin (25 μg/ml) and cultured at 37 °C for 7 h. Protein expression 
was then induced with isopropyl β-D-1-thiogalactopyranoside (Amresco, USA) at a 
final concentration of 0.3 mM. Cells were then incubated at 37 °C for 2 h and 
harvested by centrifugation at 4,400 x g for 20 min. Cell pellets were resuspended in 
40 ml Column buffer (20 mM Tris HCl, 8 M Urea, 500 mM NaCl, 20 mM Imidazole, 
1 mM β-mercaptoethanol, pH 8.0), sonicated at 10,000 Hz in an ice-water bath, 
centrifuging at 4,400 x g for 20 min. Supernatants were then loaded onto a His 
SpinTrap (GE Healthcare, UK) column in accordance with the manufacturer’s 
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instructions. Purified proteins were stored at -20 °C until required. 
 
SDS-PAGE and Western blot 
Purified recombinant proteins were confirmed by SDS-PAGE and Western 
blotting. In brief, purified recombinant proteins diluted with sample buffer were 
denatured by boiling for 10 min at 100 °C, electrophoresed, and visualized using 
Coomassie Brilliant Blue R-250 (Intron, Korea). For Western blot, proteins were 
resolved by SDS-PAGE and electro-transferred to nitrocellulose membranes 
(Invitrogen, USA) for 25 min using an iBlot©  transfer device (Invitrogen, USA). 
Membranes were incubated in 5 % skim milk (BD, USA) solution for 1 h at room 
temperature (RT), and washed 3 times with washing buffer (TBS). Proteins were 
probed with anti-histidine (1:2,000 dilution, AprilBio Co., Ltd, Korea) by incubation 
for 3 h at RT. Unbounded antibodies were removed by washing (3 x 10 minutes) 
with the same buffer. Membranes were then incubated with alkaline phosphatase 
(AP)-conjugated goat anti-mouse IgG antibody (1:2,000; Bethyl, USA,) for 1 h at 
RT. After a final wash, proteins were visualized using the AP conjugate substrate kit 
(Bio-Rad, USA). 
 
Cytokines and Nitric oxide (NO) measurements in RAW 264. 7 cells 
RAW 264.7 cells (a murine macrophage cell line; 1 x 106 cells/ml) were cultured 
in RPMI 1640 supplemented with 10 % fetal bovine serum (FBS), penicillin (50 
μg/ml), and streptomycin (50 μg/ml) at 37 °C under 5 % CO2 for 8 h in 12 well plates. 
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The activity of LPS contamination in recombinant proteins was inhibited by 
incubation with polymyxin B (10 μg/ml) for 30 min before stimulation. E. coli LPS 
(1 μg/ml, Sigma, USA) and DPBS (Gibco, USA) were used as positive and negative 
controls, respectively. Culture supernatants were collected at indicated times after 
stimulation. Amounts of cytokines (TNF-α, IL-6, IL-1β, IL-12p70 and IFN-γ) were 
measured using an enzyme-linked immunosorbent assays (ELISA) according to the 
manufacturer’s instructions (eBioscience Inc., USA). NO production was 
determined by measuring nitrite accumulation using the Griess reaction, as 
previously described [Im et al., 2016b]. 
 
Cytokine measurements in splenocytes of naïve mice 
To assay IFN-γ, IL-2, IL-4 and IL-5 levels, splenocytes (1 x 106 cells/ml) were 
isolated from healthy 5-week-old BALB/c female mice (Orient-Bio, Korea), and 
stimulated with 10 μg/ml of rMdh, rTsf, or rRocF. After 24 h, amounts of IFN-γ, IL-
2, IL-4 and IL-5 in culture supernatants were measured by ELISA according to the 
manufacturer’s instructions (eBioscience Inc., USA). E. coli LPS (1 μg/ml, Sigma, 
USA) and media were used as positive and negative controls, respectively. 
Elimination of LPS from B. abortus antigens was done by pretreatment with 
polymyxin B. Animal care and handling were performed after obtaining approval 
from the Seoul National University Institutional Animal Care and Use Committee 
(IACUC; approval number SNU-150302-2-1). 
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Numbers of IgG, IFN-γ and IL-4 secreting cells among mouse splenocytes 
Five 6-week-old BALB/c female mice were prepared per each group for three B. 
abortus antigens and control. Three B. abortus antigens emulsified with complete 
Freund’s adjuvant at 1st injection and with incomplete Freund’s adjuvant at 2nd 
injection. Mice were immunized with 30 μg of purified B. abortus antigens at each 
injection with 2 weeks interval. After then, splenocytes of mouse were collected at 
day 28 after 1st injection. Levels of B. abortus antigens, rMdh, rTsf and rRocF, 
specific IgG memory B cells and IFN-γ and IL-4 secreting T-cells from spleen of 
immunized mice were measured using the Enzyme-Linked ImmunoSpot assay kit 
(ELISpot Basic kit; Mabtech AB, Sweden). For IgG memory B cells, 200 μl of Mdh, 
Tsf, and RocF in PBS (50 μg/ml) was added to the ELISpot plates after pretreatemnt 
with 70 % ethanol and incubated overnight at 4 °C. For IFN-γ and IL-4 secreting T 
cells, 200 μl of monoclonal antibody against IFN-γ (AN18, 15 μg/ml) and IL-4 
(11B11, 15 μg/ml) were added to the plates and coated by overnight incubation at 
4 °C. After incubation, plates were extensively washed with PBS five times and 
blocked with RPMI1640 containing 10 % FBS for 30 min at RT. Upon removal of 
the medium, splenocytes were isolated from mice at 28 days after first immunization 
with B. abortus antigens and added to wells at 2 x 105 cells/well. Plates were 
incubated at 37 °C under 5 % CO2 for 24 h for IgG or 48 h for IFN-γ or IL-4. After 
removing the cells, 100 μl of biotinylated anti-IgG specific to IL-4 or IFN-γ 
antibodies in PBS containing 0.5 % FBS (PBS-0.5 % FBS) were added to each well. 
After incubation for 2 h at RT, plates were washed and streptavidin-HRP in PBS-
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0.5 % FBS was added and incubated for 1 h at RT. Wells were then washed with 
PBS and antigen secreting cells (ASCs) were visualized upon adding ready-to-use 
TMB substrate solution. The number of ASCs were counted using an Eli.Scan+ 
(A.EL.VIS, Germany). The experiment was performed in triplicate. 
 
Production of immunoglobulins in mice immunized with recombinant proteins 
Five 6-week-old BALB/c female mice per control and treatment groups were 
prepared each time points (3, 7, 14 and 28 days). Each group was intraperitoneally 
immunized with 30 μg of purified B. abortus antigens emulsified with complete 
Freund’s Adjuvant (CFA, Sigma, USA) on day 0 and with incomplete Freund’s 
Adjuvant (IFA, Sigma, USA) on day 14. Serum samples were obtained for the 
detection of antibody response at 3, 7, 14 and 28 days after first immunization. 
Antibody production was measured by ELISA. In brief, 96-well microplates 
(Greiner Bio One, Germany) were coated by incubating the purified B. abortus 
antigens, rMdh, rTsf, or rRocF (5 ng per well), in coating buffer (14.2 mM Na2CO3, 
34.9 mM NaHCO3, 3.1 mM NaN3, and pH 9.6) overnight at 4 °C. The plates were 
then blocked with 1 % bovine serum albumin (Sigma, USA) in PBS containing 0.1 % 
Triton X-100 (PBST) for 2 h at 37 °C. After washing with PBST, 1/200 diluted serum 
samples were reacted with coating antigens for 1 h at 37 °C. Horseradish peroxidase 
(HRP)-conjugated goat anti-mouse IgG (1:2,000, Bio-Rad, USA), IgG1 (1:2,000, 
Southernbiotech, USA), IgG2a (1:2,000, Southernbiotech, USA), and IgM (1:3,000, 
Jackson Immuno, USA) diluted in PBS containing 1 % BSA were used to detect IgG, 
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IgG1, IgG2a, and IgM, respectively. The color development was conducted using a 
3,3’,5,5’-tetramethyl-benzidine (TMB) substrate (Sigma, USA). The absorbance 
was measured using an automatic microplate reader (Molecular Device Co., USA) 
at 450 nm. The experiment was performed in triplicate. 
 
Statistical Analysis 
Statistical significance (P-value) was determined using the Student’s t test using 
SPSS version 4.0 (Statistical Package for Social Science; MS, USA). Statistical 






Purification of recombinant rMdh, rTsf, and rRocF from Brucella abortus 
Cloning of the genes encoding was performed as previously described [Sung et 
al., 2014; Im et al., 2016b]. These three genes encode for malate dehydrogenase, 
elongation factor, and arginase, respectively, in the pCold TF system led to 
expression of TF fusion proteins, which were purified using a histidine column. 
SDS-PAGE profiles indicated purified rMdh, rTsf, and rRocF were 85.71 kDa, 83.49 
kDa, and 85.19 kDa sized, respectively. The recombinant proteins expressed with 
pCold TF vector were confirmed by Western blot using anti-histidine antibody 
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(Figure 17). 
 
Productions of cytokines and NO in RAW 264.7 cells 
Amounts of TNF-α in RAW 264.7 cells stimulated with rMdh, rTsf, or rRocF were 
higher than in those stimulated with DPBS at 4 or 8 h. However, stimulation with 
rMdh and rRocF were not increased at 24 h post stimulation while the stimulation of 
rTsf group was constantly increased by time dependent manner (* P < 0.05, ** P < 
0.01) (Figure 18). Production of IL-6, IL-1β, IL-12p70, IFN-γ and NO were not 
detected in the culture supernatants of RAW 264.7 cells stimulated with either of the 
three B. abortus antigens. Thus, B. abortus antigens induced only the production of 
TNF-α in RAW 264.7 cells. 
 
Production of IFN-γ, IL-2, IL-4 and IL-5 in naïve mouse splenocytes 
Amounts of the Th1-related cytokines IFN-γ and IL-2, and those of the Th2-
related cytokines IL-4 and IL-5, in culture supernatants of the naïve mouse 
splenocytes were measured at 12 and 24 h after stimulation with rMsh, rTsf, or rRocF 
by ELISA. Productions of IFN-γ by mouse splenocytes stimulated with rMdh, rTsf, 
or rRocF were higher than those produced by non-treated controls (P < 0.01) (Figure 
19A). High levels of IL-2 production were observed at 24 h after treatment with 
rMdh or rTsf (P < 0.01) (Figure 19B). However, the Th2-related cytokines, IL-4 and 
IL-5, were not detected in the culture supernatants of the splenocytes after the 
stimulation. 
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Analysis of antigen-specific Ig and cytokine secreting cells in the splenocytes of 
mice immunized with rMdh, rTsf, or rRocF 
Numbers of IgG secreting B cells among mouse splenocytes at 28 days after 
immunization with B. abortus antigens were analyzed by ELISpot. A significant 
increase in these cells were only observed in the rMdh stimulated group (Figure 20A). 
Numbers of IFN-γ and IL-4 secreting T cells were also analyzed. Numbers of IFN-γ 
secreting T cells were significantly increased in rMdh and rTsf immunized cells (P 
< 0.05) (Figure 20B) while numbers of IL-4 secreting cells were increased by 
immunization group with rMdh, rTsf, or rRocF (P < 0.05) (Figure 20C). 
 
Production of antibodies in mice immunized with rMdh, rTsf, or rRocF 
Productions of IgG, IgG1 and IgG2a, and IgM were analyzed after immunizing 
mice with either of the three B. abortus antigens. IgM production against rMdh was 
significantly increased until day 14 post-immunization versus treatment naïve 
controls, and subsequently decreased. IgM production after immunization with rMdh, 
rTsf, or rRocF was higher than by non-treated group at day 7 (P < 0.05) (Figure 21A). 
IgG production was significantly increased by rMdh, rTsf, or rRocF from 7 days and 
plateaued at 28 days (P < 0.05) (Figure 21B). The production of IgG2a antibody was 
significantly elevated after immunization with rMdh or rTsf from 7 and 14 days after 
immunization, respectively. Antibody production peaked at 28 days in all 
experimental groups (Figure 21C). IgG1 antibody production exhibited the same 
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pattern as IgG2a antibody production (Figure 21D), although IgG1 antibody 
production was greater and commenced earlier than IgG2a antibody production after 





Brucellosis is a widespread, contagious disease that affects a variety of domestic 
animals, in which it causes abortion and sterility. Diagnosis of the disease has been 
done based on microbiological, serological, or molecular methods [Han et al., 2014]. 
Recently, researchers have focused on finding diagnostic antigens that do no exhibit 
cross-reactivity. Although several immune-reactive proteins have been suggested by 
these researchers, most of the proteins identified showed some level of cross-
reactivity. This lack of specificity might be due to poor understanding of the immune 
mechanisms associated with Brucella infections. In the present study, three 
immunodominant proteins, as identified by Western-blot analysis of the sera of B. 
abortus 2308-challenged cattle [Lee et al., 2015], were selected to have potential 
possibility for induction of immune responses after stimulation in the host and their 
in vitro and in vivo immunological responses were investigated. 
Malate dehydrogenase (Mdh) is a multimeric enzyme that plays a crucial role in 
the tricarboxylic acid cycle of prokaryotic and eukaryotic cells. B. abortus Mdh is 
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identified by in vivo-induced antigen technology (IVIAT), and the vaccination with 
bacterially expressed B. abortus Mdh enhances protection against Brucella infection 
in elk [Lowry et al., 2010]. Also, Mdh in B. abortus has been reported to be 
immunogenic and to be related to bacterial pathogenesis, especially colonization 
[Han et al., 2010]. In addition, purified recombinant Mdh expressed in pMAL vector 
has been demonstrated to be a potential specific antigen for the serological diagnosis 
and early detection of bovine brucellosis [Reyes et al., 2016]. Partial protective 
immunity to Mdh was also demonstrated in a challenge test using mice immunized 
with Toxoplasma gondii Mdh [Liu2016]. In present study, recombinant Mdh of B. 
abortus induced only TNF-α in RAW 264.7 cells and IFN-γ and IL-2 in naïve mice 
splenocytes. The patterns of TNF-α, IL-6 and NO production in RAW 264.7 cells in 
this study were different with those from our previous study with other recombinant 
proteins [Im et al., 2016b], whereas IFN-γ and IL-2 production patterns were similar 
to those observed in our previous study [Im et al., 2016b]. Numbers of antigen-
secreting cells (ASCs) among the splenocytes of mice immunized with the three 
recombinant proteins were also similar to those observed previously with the 
exception of lower number of cells compared with r0628 and rTbpA [Im et al., 
2016b]. Therefore, it was confirmed that the immunogenicity of the recombinant 
protein Mdh increased the production of cytokines associated with immune 
responses.  
Translation elongation factor EF-Tu is an essential component of the translational 
machinery, and may play additional roles. It was recently demonstrated EF-Tu is 
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released/secreted from bacterial cells and that it can modulate pathogen-host 
interactions. However, the mechanism responsible for disruption of immune 
regulation in host cells has not been determined [Nieves et al., 2010; Sharma et al., 
2011]. Furthermore, recombinant translation elongation factor of B. abortus induced 
the production of TNF-α in RAW 264.7 cells up to 12 h after stimulation while the 
productions of IFN-γ and IL-2 were increased for up to 24 h in naïve mouse 
splenocytes. This phenomenon was different with B. abortus other cellular proteins 
[Im et al., 2016b]. In this study, recombinant rTsf of B. abortus showed high 
production of cytokines and antigen-secreting cells with in vitro and in vivo 
experiments after stimulation. 
Arignase is a metalloenzyme that hydrolyzes L-arginine to ornithine and urea, and 
its two isoforms exhibit differential subcellular localizations and tissue distributions. 
Arginase I is a cytosolic enzyme that is predominantly expressed in hepatocytes, 
whereas arginase II is a mitochondrial enzyme and is expressed in brain, kidneys, 
small intestine, monocytes and macrophages [Gogoi et al., 2016]. Arginine 
metabolism is crucial for M1 and M2 polarization effects. M1 macrophages are 
proinflammatory in nature, produce NO and NO-derived peroxynitrite, and induce 
Th1 adaptive immune response [Gogoi et al., 2016]. M2 macrophage differentiation 
is induced by elevated arginase levels and gives rise to anti-inflammatory and anti-
parasitic Th2 responses [Gogoi et al., 2016]. 
Although RocF has been identified as an immunoreactive protein by Western blot 
with sera from B. abortus 2380-challenged cattle, the role of RocF in immune 
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response has not been determined [Lee et al., 2015]. In the present study, rRocF 
induced the productions of TNF-α and IFN-γ and the production of IgG in mice 
immunized with B. abortus antigens. Also, numbers of IL-4 secreting cells were 
increased among splenocytes of mice 28 days after immunization with B. abortus 
antigens. These results indicate RocF could be related with the induction of Th2 
types of immune response. Collectively, our study suggests that these three cellular 
proteins of B. abortus might induce strong Th2-type related immune responses in 
vivo. Moreover, three B. abortus antigens could be a candidate biomarker for 
studying pathogenesis of Brucella infection or developing vaccine of brucellosis.  
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Table 4. Primer sequences used for the cloning Brucella abortus genes 






Malate dehydrogenase  
(Mdh) 
F: AATTCGGATCCATGGCACGCAACAAGATT 
63 963 [Im et al., 2017] 
R: AGGCGTCGACTTATTTCAGCGACGGAGC 
Elongation factor  
(Tsf) 
F: AATTCGAATTCATGAGCATTTCCGCATCT 





63 918 [Im et al., 2017] 
R: AGGCCTGCAGTCAATAGCTGATGGTCGG 
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Figure 17. Analysis of purified recombinant Mdh, Tsf, and RocF of Brucella abortus. 
SDS-PAGE (A) and Western blot (B) analysis of soluble protein fractions of pCold 
TF expressed with expected size. M: molecular weight markers, Lane 1: rMdh (85.71 
kDa), Lane 2: rTsf (83.49 kDa), Lane3: rRocF (85.19 kDa), Lane 4: vehicle (52 kDa).   
 - 73 - 
 
 
Figure 18. Productions of TNF-α in RAW 264.7 cells stimulated with B. abortus 
antigens. Only rTsf increased the production of TNF-α until 24 h after stimulation, 
whereas rMdh and rRocF increased the production of TNF-α at 4 and 8 h versus 
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Figure 19. Productions of IFN-γ and IL-2 by naïve mouse splenocytes. (A) 
Production of IFN-γ was increased at 12 and 24 h after stimulating cells with purified 
rMdh, rTsf, or rRocF. (B) Production of IL-2 was increased at 24 h after stimulating 
cells with purified rMdh or rTsf. The production of IFN-γ was induced in splenocytes 
after stimulation with all three B. abortus antigens groups compared to the control 
group. The production of IL-2 in splenocytes was induced in the two experimental 
groups stimulated with rMdh and rTsf compared to control group. (** P < 0.01). 
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Figure 20. Numbers of antigen-secreting cells (ASCs) in the splenocytes of mice 
immunized with rMdh, rTsf, or rRocF of Brucella abortus. (A) Total IgG production 
was increased by rMdh at 28 days post-immunization. (B) Production of IFN-γ was 
at 28 days post-immunization with rMdh or rTsf. (C) Production of IL-4 was 
increased at 28 days post-immunization by rMdh, rTsf, or rRocF. Three B. abortus 
antigens induced different number of antigen-secreting cells after the stimulation. Of 
the cellular antigens of B. abortus, rMdh showed higher antigenicity compared to 
other B. abortus antigens. (* P < 0.05, ** P < 0.01). 
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Figure 21. Humoral immune responses (IgM, IgG, IgG2a and IgG1) in mice 
immunized with rMdh, rTsf, or rRocF. (A) IgM production was increased at 7 days 
post-immunization with rMdh, rTsf and rRocF. rMdh had the greatest effect on IgM 
production at 14 days post-immunization. (B) IgG production was time-dependently 
increased by immunization with rMdh, rTsf and rRocF. Productions of IgG2a (C) 
and of IgG1 (D) were induced 7, 14, and 28 days after immunization with rMdh, rTsf, 
or rRocF, respectively. Therefore, all three B. abortus antigens, rMdh, rTsf, rRocF, 
showed the production of the antibodies by time-dependent. Especially, IgG, IgG2a 
and IgG1 productions were highly increased at 28 day while the production of IgM 
was increased at early time after stimulation with three B. abortus antigens. (* P < 
0.05, ** P < 0.01). 
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Chapter III 
 
Comparative Analysis of Immune Responses in in 
vitro and in vivo after Stimulation of Brucella 
abortus Outer Membrane Antigens, OMP10, 




Brucella infection is accompanied by cytokine production, which serves as an 
important factor to evaluate the innate and adaptive immune responses. Several 
researchers have been investigating the mechanisms involved in Brucella infection 
in the host. Here, we conducted an analytical study to define pathogenic pathways 
and immune mechanisms involved in Brucella infection by investigating the 
antigenic efficacy of recombinant outer membrane protein 10 (rOMP10), outer 
membrane protein 19 (rOMP19), and outer membrane protein 28 (rOMP28) in vitro 
and in vivo upon stimulation/immunization. Cytokine production was analyzed by 
nitric oxide (NO) assay and enzyme-linked immunosorbent assay (ELISA) after 
stimulation of RAW 264.7 cells and naive splenocytes with B. abortus antigens. Our 
 - 78 - 
results show that levels of NO, tumor necrosis factor (TNF)-α, and interleukin (IL)-
6 increased in RAW 264.7 cells in a time-dependent manner following B. abortus 
antigens stimulation. In contrast, levels of interferon (IFN)-γ and IL-2 increased in 
naive splenocytes after stimulation with B. abortus antigens. ELISA and ELISpot 
assays were performed after immunization of mice with B. abortus antigens. 
rOMP28 greatly increased IFN-γ, IL-2, and TNF-α levels than IL-4 and IL-6 levels 
in vitro. Of the B. abortus antigens, rOMP19 elicited a mixed Th1/Th2 immune 
response by increasing the number of IgG-secreting cells in vivo. 
 
Keywords: Brucella abortus, Cytokine, Immunogenicity, Outer membrane protein, 
B. abortus antigens. 
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Introduction 
 
Brucella is a Gram-negative bacterium and causative agent of a serious zoonotic 
disease, brucellosis. The genus Brucella has been classified according to its primary 
preferred host and antigenic variations [Ko et al., 2003; Foster et al. 2007; Scholz et 
al., 2010; Whatmore et al., 2014]. Brucella infections induce a variety of clinical 
symptoms in both animals and humans [Franco et al., 2007].  
Brucella spp. are able to easily establish chronic infections in the host cell by 
avoiding lysosomal degradation and maintaining proliferation within macrophages 
[Detilleux et al., 1990a; Detilleux et al., 1990b]. Lipopolysaccharide (LPS) is the 
most important virulence factor that activates the innate immune system; Brucella 
strains are deficient in LPS and, hence, have lesser virulence and stronger ability to 
survive. However, LPS-based serological tests may give false-positive results, owing 
to the similarity between Brucella and gram-negative bacteria, such as Yersinia 
enterocolitica O:9 [Kittelberger et al., 1998], Escherichia coli [Oñate et al., 1999], 
and Salmonella urbana [Nielsen et al., 2007]. Therefore, several studies have aimed 
to investigate other factors, such as outer membrane proteins (OMPs) and their 
potential applications as diagnostic markers and vaccines against brucellosis [Sowa 
et al., 1991; Tibor et al., 1996; Kovach et al., 1997]. Recent studies have focused on 
various OMPs, such as OMP28, OMP2b, OMP10, OMP16, and OMP19 [Tibor et 
al., 1999; Sung et al., 2014; Simborio et al., 2015]. Of these, OMP28 displays 
significant potential as a diagnostic candidate that may trigger protective effects in 
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vivo and show high efficiency in serological tests against brucellosis [Lindler et al., 
1996; Lim et al., 2012a; Lim et al., 2012b; Tiwari et al., 2013]. Attempts have been 
made to clone these OMPs and other proteins to investigate if their immunogenicities 
may allow LPS-free diagnosis following infection with Brucella spp.   
Immune responses in the host are caused following pathogenic infection, which 
triggers the production of proinflammatory cytokines, such as interleukin (IL)-1β, 
IL-4, IL-6, IL-12, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α. The 
production of these cytokines results in the disturbance of immune responses in the 
host, as these molecules participate in cellular and/or humoral immune responses 
[Gu et al., 2013; Im et al., 2016b]. Therefore, the analysis of the cytokine production 
may explain the correlation between the invasion and localized inflammation by B. 
abortus infection. Many researchers have reported Th1 (cellular) and Th2 (humoral) 
immune responses following infection [Barquero-Calvo et al., 2013; Im et al., 
2016b]. Although several immunogenic antigens have been investigated, only a few 
immune mechanisms have been identified in brucellosis.   
In this study, 3 B. abortus antigens, rOMP10, rOMP19, and rOMP28, were 
selected to study the pathogenic pathways and evaluate their immunogenicities in 




Materials and Methods 
 - 81 - 
 
Construction of OMP10, OMP19, and OMP28 expression clones 
Total genomic DNA was prepared from Brucella abortus 544 (ATCC23448) 
culture using a G-spinTM Genomic DNA Extraction kit for bacteria (Intron, Korea). 
Genes encoding OMP10, OMP19, and OMP28 of B. abortus were amplified by PCR 
with primers pairs: OMP10 sense 5’-AGCAGAATTCATGAAACGCTTCCGCA-3’, 
OMP10 anti-sense 5’-ATTACTGCAGTCAGCCGGCGTTGC-3’, OMP19 sense 5’-
AGCAGGATCCATGGGAATTTCAAAAGCAAG-3’, OMP19 anti-sense 5’-
ATACTGCAGTCAGCGCGACAGCG-3’, and OMP28 sense 5’-
GATCGGATCCAACACTCGTGCTAGCAATTTT-3’, OMP28 anti-sense 5’-
GATCAAGCTTTTACTTGATTTCAAAAACGAC-3’. The amplified DNA were 
digested with appropriate restriction enzymes, then ligated into a pCold TF vector 
(Takara, Japan), in which the recombinant proteins were expressed fused to the TF 
agent.  
 
Expression and purification of rOMP10, rOMP19, and rOMP28 proteins 
The expression and purification of recombinant proteins were modified as 
previously described [Lim et al., 2012a]. Briefly, E. coli containing the fusion 
plasmid were cultured by inoculating 20 ml of the bacteria into one liter of ampicillin 
containing LB broth and incubated at 37 °C for 7 h. Isopropyl β-D-1-
thiogalactopyranoside (IPTG, Amresco, USA) was then added to a final 
concentration of 0.3 mM and further incubated at 37 °C for 2 h. Bacterial cells were 
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subsequently harvested by centrifugation at 4,400 x g for 20 min, after which the 
supernatant was discarded and resuspended in 40 ml of column buffer (20 mM Tris 
HCl, 8 M Urea, 500 mM NaCl, 20 mM Imidazole, 1 mM β-mercaptoethanol, pH 
8.0). The samples were then sonicated at 10,000 Hz in an ice-water bath and 
centrifuged at 4,400 x g for 20 min to collect the supernatant. The supernatant was 
then loaded into a His SpinTrap (GE Healthcare, UK) column according to the 
manufacturer’s instructions. 
 
SDS-PAGE and Western blot 
The purified recombinant proteins were diluted with sample buffer and boiled for 
10 min at 100 °C. After electrophoresis, samples were visualized by staining with 
Coomassie Brilliant Blue R-250 (Intron, Korea). Proteins resolved by SDS-PAGE 
were transferred to nitrocellulose membrane (Invitrogen, USA) for 25 minutes using 
an iBlot© transfer device (Invitrogen, USA). Next, membranes were blocked by 
incubation in 5 % skim milk (BD, USA) for 1 h at room temperature (RT), washed 
three times with TBS, and then incubated with anti-histidine (1:2,000 dilution, 
AprilBio Co., Ltd, Korea) for 3 h at RT. The membranes were washed again three 
times for 10 min, after which they were incubated with alkaline phosphatase (AP)-
conjugated goat anti-mouse IgG antibody (1:2,000 dilution, Bethyl, USA,) for 1 h at 
room temperature. After the final wash, proteins were visualized with an AP 
conjugate substrate kit (Bio-Rad, USA). 
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Production of nitric oxide (NO) and cytokines in RAW 264.7 cells 
After incubating RAW 264.7 cells for 8 h in 12 well plates containing 1 x 106 
cells/ml, they were stimulated with 10 μg/ml rOMP10, rOMP19, and rOMP28. 
Contamination by LPS in B. abortus antigens was inhibited by incubation with 
polymyxin B (10 μg/ml) for 30 min before stimulation of macrophages. The culture 
supernatants were collected 4, 8 and 24 h after stimulation. The amounts of TNF-α, 
IL-6, IL-1β, IL-12p70, and IFN-γ were measured using an enzyme-linked 
immunosorbent assay (ELISA) according to the manufacturer’s instruction 
(eBioscience inc., USA). The level of NO was determined by measuring the nitrite 
accumulation based on Griess reagent system. 
 
Production of cytokines in naïve splenocytes of mice 
For the IFN-γ, IL-2, IL-4 and IL-5 assays, splenocytes (1 x 106 cells/ml) were 
isolated from healthy female BALB/c mice that were 5-weeks of age (Orient-Bio, 
Korea) and then stimulated with 10 μg/ml of rOMP10, rOMP19, and rOMP28. After 
24 h, the amounts of IFN-γ, IL-2, IL-4 and IL-5 in the culture supernatants were 
measured by ELISA according to the manufacturer’s instructions (eBioscience Inc., 
USA). LPS (Sigma, USA) and media were used as positive and negative controls, 
respectively. All stimuli were pretreated with polymyxin B to avoid the activity of 
LPS contamination. All care and handling of animals was performed with the 
approval of the Seoul National University Institutional Animal Care and Use 
Committee (IACUC) and approval number was SNU-150302-2-1. 
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Production of immunoglobulins and antigen (OMPs)-specific antibodies in mice 
immunized with recombinant proteins. 
We immunized 6-week-old BALB/c mice with an intraperitoneal injection of 30 
μg purified B. abortus antigens, rOMP10, rOMP19, or rOMP28 mixed with 
complete Freund’s Adjuvant (CFA, Sigma) on day 0 and incomplete Freund’s 
Adjuvant (IFA, Sigma) on day 14. Five mice were immunized with B. abortus 
antigens for each group. Sera for antibody response detection were obtained on 3, 7, 
14, and 28 days after the first immunization. Briefly, 96-well microplates were 
coated by incubating purified B. abortus antigens (5 ng/well) in a coating buffer 
(14.2 mM sodium carbonate [Na2CO3], 34.9 mM sodium bicarbonate [NaHCO3], 
and 3.1 mM sodium azide [NaN3], pH 9.6) overnight at 4 °C for ELISA. The plates 
were blocked with 1 % bovine serum albumin (BSA; Sigma) in a solution of 
phosphate-buffered saline (PBS) containing 0.1 % Triton X-100 (PBST) for 2 h at 
37 °C. After washing with PBST, 1/200 diluted serum sample was added to the wells 
and incubated for 1 h at 37 °C. Horseradish peroxidase (HRP)-conjugated goat 
antimouse IgG, IgG1, IgG2a (1:2,000, Bio-Rad), and IgM (1:3,000, Jackson 
Immuno Research, West Grove, PA, USA) diluted in PBS containing 1 % BSA were 
used to detect IgG, IgG1, IgG2a, and IgM, respectively. Color developed when the 
substrate, 3,3′,5,5′-tetramethyl-benzidine (TMB) (Sigma), was added. The 
absorbance was measured at 450 nm using an automatic microplate reader 
(Molecular Device Co., Silicon Valley, CA, USA). The levels of antibodies specific 
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to rOMP10, rOMP19, and rOMP28 were measured after incubation of sera from 
mice immunized with B. abortus antigens at 37 °C for 1 h. For the detection of 
antibodies specific to B. abortus antigens, 96-well microplates were coated with 
purified B. abortus antigens (25 ng/well) in the coating buffer overnight at 4 °C. The 
plates were blocked with 1 % BSA in PBST for 2 h at 37 °C. After washing with 
PBST, 1/160 diluted serum sample was added to the wells and incubated for 1 h at 
37 °C. HRP-conjugated goat anti-mouse IgG (H+L) (1:2,000, Bio-Rad) diluted in 
PBS containing 1 % BSA was used to detect IgG. Color developed when the 
substrate, TMB, was added, and the absorbance was measured at 450 nm using an 
automatic microplate reader. 
 
Measurement of cells secreting IgG, IFN-γ, and IL-4 in mouse splenocytes 
Recombinant rOMP10-, rOMP19-, and rOMP28-specific IgG memory B cells and 
T cells secreting IFN-γ and IL-4 from spleens of immunized mice were measured 
using an enzyme-linked immunospot (ELISpot Basic) assay kit according to the 
manufacturer’s instructions (Mabtech AB, Stockholm, Sweden). The number of cells 




Statistical significance was calculated with Student’s t-test using the Statistical 
Package for Social Science (SPSS) software version 4.0 (MS, Chicago, IL, USA). 
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Differences were considered to be significant if a value of P < 0.05 was obtained. 





Cloning and purification of recombinant OMP10, OMP19, and OMP28 of B. 
abortus 
Cloning of genes encoding OMP10, OMP19, and OMP28 was performed as 
described in a previous study [Simborio et al., 2015] with some modifications. SDS-
PAGE profiles revealed the size of purified rOMP10, rOMP19, and rOMP28 to be 
approximately 65.86, 71, and 80 kDa, respectively (Figure 22A). Western blot 
analysis was performed to evaluate the cellular antigens of B. abortus after protein 
purification, and the expected sizes of rOMP10, rOMP19 and rOMP28 were 
determined (Figure 22B).   
 
Production of NO and inflammatory cytokines in RAW 264.7 cells 
We failed to observe any increase in NO production in groups stimulated with 
rOMP10 and rOMP28 at 24 h. On the other hand, cells stimulated with rOMP19 
showed an increase in NO production at 24 h as compared to the control group (P < 
0.01) (Figure 23A). The level of TNF-α detected in groups stimulated with all 3 B. 
abortus antigens was higher than that observed in the control group and these 
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changes occurred in a time-dependent manner (Figure 23B). The production of IL-6 
increased after 8 h in response to stimulation with rOMP10 and rOMP19. In contrast, 
stimulation with rOMP28 induced the production of IL-6 at 24 h after stimulation 
(Figure 23C). We failed to detect IL-1β, IL-12 and IFN-γ in cells stimulated with B. 
abortus antigens. Thus, B. abortus antigens showed immune-stimulating activities 
in RAW 264.7 cells, as evident from the production of TNF-α and IL-6. 
 
Production of IFN-γ and IL-2 in naïve mouse splenocytes  
The production of IFN-γ was higher in mouse splenocytes stimulated with 
rOMP28 as compared with the control group and differences were observed in a 
time-dependent manner (P < 0.01) (Figure 24A). In addition, the level of IL-2 
increased in cells treated with rOMP28 as compared with the control group at 24 h 
(P < 0.01) (Figure 24B). Therefore, rOMP28 induced high immune-stimulating 
activities through the production of IFN-γ and IL-2 in naive mouse splenocytes. 
 
Analysis of antigen-secreting cells in splenocytes from mice immunized with 
rOMP10, rOMP19, and rOMP28 
The number of antigen-specific IgG-secreting B cells from mice splenocytes was 
analyzed using ELISpot following 28 days of immunization with B. abortus antigens. 
The number of antigen-specific IgG secreting B cells significantly increased in mice 
immunized with rOMP19 compared that in mice in the nonimmunized group, while 
no increase was observed in response to rOMP10 and rOMP28. No difference was 
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reported in the number of IFN-γ- and IL-4-secreting T cells involved in the 
production of Th1-related and Th2-related cytokines, respectively, for the groups 
(Table 5). 
 
Production of antibodies in mice immunized with rOMP10, rOMP19, and 
rOMP28 
The production of antibodies specific to each recombinant protein was confirmed 
from the sera obtained in the in vivo immunoreactivity test (Figure 25). The B. 
abortus antigen-specific antibody was generated on day 7 after immunization 
(Figrue 25A, B). However, the level of antibody to rOMP28 was found to be lower 
than that for other B. abortus antigens (Figure 25C). Nevertheless, this observation 
suggests that B. abortus antigens used in this study may induce protein-specific 
immune responses in vivo. The level of IgM antibody against rOMP28 was 
significantly increased compared with that in the control group on day 3, while the 
level of antibody to rOMP19 increased on day 14 (P < 0.05) (Figure 26A). The level 
of IgM produced in groups immunized with each of the 3 B. abortus antigens was 
similar to that observed in the control group on days 7 and 28, while the level of IgG 
in all 3 recombinant groups was significantly higher than that in the control group 
on day 14 after immunization (P < 0.01) (Figure 26B). Stimulation with rOMP19 
led to an increase in the production of IgG1 after 3 days, whereas rOMP28 group 
showed an increase in IgG1 level after 14 days. The production of Th1-related 
antibody, IgG2a, gradually increased in rOMP19 group after 7 days, but only after 
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28 days of immunization in rOMP10 and rOMP28 groups. On day 28, all 3 groups 
showed an increase in the level of IgG2a compared with the control group (Figure 
27A). The production of Th-2 related antibody, IgG1, in rOMP10 group was 
significantly increased on day 3, while that in rOMP19 group increased 7 days after 
immunization. All 3 groups showed an increase in IgG1 level on day 14 after 





In this study, we cloned and expressed the 3 genes encoding immunogenic outer 
membrane proteins as B. abortus antigens using pCold TF expression system 
[Simborio et al., 2015]. B. abortus antigens were identified with SDS-PAGE and 
western blot analysis at their expected sizes following purification using anti-
histidine column. In addition, it was evaluated immunological characteristics of 
these cellular antigens from B. abortus.   
Many studies have focused on the investigation of immune responses, including 
evaluation of the production of proinflammatory cytokines such as TNF-α, IL-6, 
IFN-γ, and IL-4 following stimulation and/or immunization with various antigens of 
Brucella spp. in vitro [Gu et al., 2013; Sung et al., 2014; Hop et al., 2015]. Selected 
B. abortus antigens, rOMP10, rOMP19 and rOMP28, induced the production of 
TNF-α and IL-6 in RAW 264.7 cells after 4 and 8 h of stimulation. The protein 
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rOMP19 induced the production of exceptionally high levels of these cytokines than 
other B. abortus antigens, consistent with the results of other studies [Zhan et al., 
1993; Giambartolomei et al., 2004; Sung et al., 2014]. The production of NO 
significantly increased 24 h after stimulation of cells with rOMP19 as compared with 
control. The production of IFN-γ and IL-2 was high at 24 h after stimulation with 
rOMP28 in splenocytes from naive mice, whereas the stimulation with rOMP10 and 
rOMP19 induced the production of these cytokines at very low levels. IFN-γ is one 
of the major cytokines used to evaluate immune response both in vitro and in vivo 
after stimulation or immunization with B. abortus antigens. These results imply that 
rOMP28 triggered Th1 cell-mediated immune response via secretion of IFN-γ and 
IL-2. These findings are in line with the observation of high level of IFN-γ produced 
in splenocytes by other antigen sources without LPS [González-Smith et al., 2006; 
Cha et al., 2010; Sung et al., 2014]. The production of antigen-specific IgM and IgG 
was observed in mice immunized with these 3 B. abortus antigens. The production 
of antigen-specific IgM was lower than that of antigen-specific IgG. All 3 B. abortus 
antigens showed strong antigen-specific IgG production 28 days after stimulation. 
In particular, rOMP19 showed the strongest immunogenicity from day 3 to 28 after 
immunization. Moreover, IgG1 and IgG2a production increased in a time-dependent 
manner, indicative of the shift of immunological response from Th1- to Th2-
mediated response. The production of antigen-specific IgG-secreting B cells and 
IFN-γ- or IL-4-secreting T cells in the spleen was observed in mice immunized with 
rOMP10, rOMP19, and rOMP28. However, no difference was observed in levels of 
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IFN-γ- or IL-4-secreting T cells in mice immunized with the 3 B. abortus antigens 
as compared with the control group. Therefore, results of this study contribute to the 
understanding of the immunogenicity of rOMP10 and rOMP19. These OMPs have 
been generally studied to develop vaccines against diseases caused by various 
species, including Anaplasma marginale [Ducken et al., 2015], S. enterica [Hamid 
et al., 2008], Haemophilus parasuis [Li et al., 2016], and E. coli [Montero et al., 
2014]. Pathogenic infections against host cells and the consequent cytokine 
production have been investigated thoroughly in the field of immunology and 
vaccine development [Eckmann et al., 2001; Luo et al., 2003; Boer et al., 2015; 
Hicks et al., 2015]. Thus, the evaluation of proinflammatory cytokine production is 
essential for the analysis of the protective immunity against pathogens. IFN-γ, IL-2, 
IL-4, IL-6 and TNF-α are some of the major target cytokines used to evaluate 
immunogenicity after stimulation and/or immunization with B. abortus antigens. In 
addition, IFN-γ and IL-2 are induced by spleen cells after immunization with live 
antigens [Zhan et al., 1995]. IgG response is another factor involved in imparting 
protection against antigens. These results indicate that B. abortus antigens drive a 
shift from Th1 to Th2 immune responses after immunization of mice. Some studies 
have reported that Th1/Th2 balance is disturbed in response to stress or infection by 
antigens, resulting in the shift toward Th2-dominant immunity [Iwakabe et al., 1998; 
Elenkov et al., 2004]. Furthermore, the levels of IgG1 and IgG2a were shown to 
increase after immunization with the recombinant outer membrane protein 25 in 
mice, although no significant increase in cytokine-secreting splenocyte population 
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was observed [Goel et al., 2012].   
In conclusion, this study evaluated the immunogenicities of 3 cellular antigens 
(rOMP10, rOMP19 and rOMP28) of B. abortus by determining various immune 
responses. Of rOMPs, rOMP10 and rOMP19 showed strong immune responses in 
vitro and in vivo, although we failed to observe any significant increase in levels of 
IFN-γ and IL-2 in naive mice splenocytes. Thus, these proteins may serve as possible 
candidates for further investigation of the pathogenesis of Brucella infection. 
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Table 5. Number of antigen-secreting cells (ASC) from splenocytes of mice 
immunized with rOMP10, rOMP19, and rOMP28 of Brucella abortus at 28 days 








PBS 36.17 ± 13.96 5.5 ± 1.11 27.5 ± 4.28 
rOMP10 28.5 ± 7 3.75 ± 5.19 14.5 ± 3.87 
rOMP19 210.75 ± 35.42** 8.25 ± 3.77 31.25 ± 7.63 
rOMP28 30 ± 4.16 7.25 ± 2.87 18.75 ± 8.81 
  





Figure 22. Analysis of purified recombinant OMP10, OMP19, and OMP28 of B. 
abortus. SDS-PAGE (A) and Western blot (B) analysis of soluble protein fractions 
of pCold TF expressed with expected size. M: molecular weight markers, Lane 1: 
outer membrane protein 10 (OMP10) (65.86 kDa), Lane 2: outer membrane protein 
19 (OMP19) (71 kDa), Lane 3: outer membrane protein 28 (OMP28) (80 kDa), Lane 
4: TF protein (52 kDa). 
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Figure 23. Production of nitric oxide (NO) and cytokines in RAW 264.7 cell after 
stimulation with B. abortus antigens. (A) Production of NO was increased after 
stimulation with rOMP19 at 24 h. (B) Production of TNF-α was significantly 
increased after stimulation with rOMP10, rOMP19, and rOMP28 in a time dependent 
manner. (C) Production of IL-6 was increased after 8 h of stimulation with rOMP10 
and rOMP19, whereas stimulation with rOMP28 induced production of IL-6 at 24 h. 
(** P < 0.01). 
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Figure 24. Production of IFN-γ and IL-2 by naïve mice splenocytes. (A) Production 
of IFN-γ was increased after stimulation with purified rOMP28 at 12 h and 24 h post 
stimulation. (B) Production of IL-2 was increased after stimulation with purified 
rOMP28 at 24 h post stimulation. (** P < 0.01).  
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Figure 25. Detection of antigen-specific antibodies in immunized mice after reaction 
with recombinant TF protein. Antibodies to the rOMP10 and rOMP19 cellular 
antigens were increased at Day 14 after immunization except the rOMP28 
immunized group. The production of antibodies the rOMP10 (A), rOMP19 (B) and 
rOMP28 (C) proteins were detected by ELISA using the sera from the 3 B. abortus 
antigens immunized mice groups. The antibodies to B. abortus antigens were 
produced time-dependent manner. At 28 days after the immunization, the production 
of all antibodies were increased in the 3 immunized mice groups (rOMP10, rOMP19 
and rOMP28) compared to control mice group. (* P < 0.05, ** P < 0.01).  
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Figure 26. Humoral immune responses induced in mice by immunization with 
rOMP10, rOMP19 and rOMP28 of B. abortus (IgM and IgG). (A) Different levels 
of IgM production were observed after immunization with rOMP28 protein at 3 days 
and rOMP19 protein at 14 days. (B) Production of IgG was increased after 
immunization with rOMP10, rOMP19 and rOMP28 in a time dependent manner. 
Stimulation of rOMP19 increased from 3 days after immunization. (* P < 0.05, ** 
P < 0.01).  
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Figure 27. Humoral immune response induced IgG2a and IgG1. Production of 
IgG2a (A) was induced by immunization with rOMP19 after 7 days, while it was 
induced by rOMP10 and OMP28 after 28 days. Production of IgG1 (B) was induced 
immunization with OMP10 after 3 days, and OMP19 after 7 days. IgG1 production 
increased 14 days after stimulation with the 3 B. abortus antigens. (* P < 0.05, ** P 
< 0.01).  
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Chapter Ⅳ 
 
Cytokines Production and Expression of Toll-like 
Receptors in Human Leukemic Monocyte Cells, 





A zoonotic pathogen, Brucella spp. is the causative agent of brucellosis, which 
results in abortion and loss in milk production in domestic animals, and undulant 
fever, osteoarticular pain and splenomegaly in humans. Due to the capability of the 
bacteria to modulate the host cell functions and survive in macrophages, early 
detection and eradication of the intracellular bacteria has received significant 
attention. Moreover, understanding the immunological alterations in Brucella 
infection is crucial to help develop control measures. Cytokines and toll-like 
receptors (TLRs) are some of the major compounds that play important roles in 
modulating the innate immunity and acquired immunity in host after infection. In 
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this study, therefore, human leukemic monocyte cells (THP-1 cells) were stimulated 
with five B. abortus cellular antigens: outer membrane protein 10 (OMP10), outer 
membrane protein 19 (OMP19), thiamine transporter substrate-binding protein 
(TbpA), arginase (RocF) and malate dehydrogenase (Mdh). Post stimulation, the 
cytokine productions and TLR expressions in the cells were evaluated at different 
time points (12 and 24 h), and analyzed using ELISA and real time RT-PCR, 
respectively. In the production of cytokines, it was observed that the production of 
TNF-α and IL-6 was highly induced in THP-1 cells stimulated with five B. abortus 
antigens. Also, TLR8 was induced in a time-dependent manner after stimulation with 
two B. abortus antigens, rOMP19 and rMdh, until 24 h. These results suggest that 
the two B. abortus antigens, rOMP19 and rMdh, might be involved in TLR8 
signaling pathway in THP-1 cells in a time-dependent manner. These two B. abortus 
antigens are therefore potentially effective antigen candidates which would help to 
provide better understandings of the immune responses after Brucella infection.  
 
Keywords: Brucella abortus, B. abortus antigens, Cytokines, TLRs, THP-1. 
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Introduction 
 
Brucellosis is a serious zoonotic disease caused by the Brucella spp., a Gram-
negative bacteria. It is indicated by undulant fever, endocarditis, arthritis and 
osteomyelitis in humans, and abortion and infertility in animals [Franco et al., 2007]. 
Depending on the major preferred host and antigenic variation, the Brucella genus 
is classified into twelve species. B. abortus has received attention due to its 
significant clinical and economic importance. The Brucella spp. establish a chronic 
infection in the host cells by evasion of the host bactericidal phagocyte functions, 
and proliferate within the macrophages [Detilleux et al., 1990a; Detilleux et al, 
1990b]. 
Although numerous researches have developed control measures including 
diagnostic methods against the bacterial infection through investigation of 
pathological pathways, several points still need to be addressed. Lipopolysaccharide 
(LPS) is regarded as the most important antigen during the immune response in 
brucellosis [Ko et al., 2003]. Moreover, diagnosis of B. abortus in ruminant is mainly 
based on the serological confirmation with LPS-based antigens. The LPS-test based 
on this antigen could therefore give false positive results. Hence, many researchers 
have tried to develop diagnostic reagents without LPS [Al Dahouk et al., 2006]. 
Recently, brucellosis has been actively investigated using the Brucella 
recombinant proteins and Brucella mutants for alternative diagnostic factors and 
vaccines [Boschiroli et al., 1997; Wang et al., 2011; Tan et al., 2012]. Many research 
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groups have especially concentrated on studying to overcome the disadvantages of 
LPS-based diagnostics, and to develop more effective diagnostics and vaccines using 
various recombinant proteins. Among the recombinant proteins reported, the focus 
has been on the outer membrane protein28 (OMP28) has as an immunogen with high 
potency. Additionally, other Brucella cellular proteins such as OMP10, OMP19, 
OMP2b and SodC are reported to be effective antigens in inducing an immune 
response [Sung et al., 2014; Simborio et al., 2015; Im et al., 2016b]. 
Cytokines have important roles in provoking the direction of immune responses, 
either cellular and/or humoral immunity. The cytokines, interleukin 1 (IL-1), 
interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), are produced in 
macrophages through the cellular immune response which induces the early immune 
responses [Zhan and Cheers, 1995]. Moreover, the productions of interferon gamma 
(IFN-γ) and interleukin 10 (IL-10) are known to be secreted from the CD4+ T cells 
in Brucella infection. These factors enhance the protection and/or alleviate the 
infection due to Brucella, via induction of the immune response [Stevens et al., 1992; 
Ferenandes and Bladwin, 1995]. In humoral immunity, the levels of IgG, IgM, or 
IgA classes of antibodies are known to be important factors to help estimate the 
immune protection against Brucella infection. It can investigate the immune 
response which is changed by bacterial antigens invasion through the productions of 
the cytokines and antibodies. 
Toll-like receptors (TLRs) are important factors in the immune response in cells, 
and are responsible for the signaling of infectious agents into cells. There are 10 TLR 
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families in humans, and 12 TLR families in mice. More specifically, TLR1-9 is 
common to both mouse and human. In mice, the function of TLR10 is limited, while 
in humans there is a role. In addition, TLR11-13 is present in mice while not present 
in humans [Kawai and Akira, 2010]. Of these, TLR4 is a known receptor related to 
cell apoptosis during infections, while TLR8 mediates the signals that inhibit cell 
apoptosis. Intracellular signaling pathways by B. abortus infection are mediated by 
mitogen-activated protein kinases (MAPKs) and nuclear factor kappa B (NF-κB) 
[Gomes et al., 2012]. This process is depending on the myeloid differentiation factor 
88 (MyD88) and interleukin-1 receptor-associated kinases 4 (IRAK-4). Another 
study has further reported the importance of TLR9 in B. abortus infection [Gomes 
et al., 2012]. 
This study, therefore, compared the changes in cytokine production and 
expression of genes involved in the TLR-related pathways in the intracellular 
immunity-inducing response of human leukemic monocyte cells, THP-1 cells, 
stimulated with B. abortus antigens, rMdh, rOMP10, rOMP19, rRocF and rTbpA. 
This research could be considered as basic data to further study the immunogenicity 
by intracellular invasion of Brucella. 
 
 
Materials and Methods 
 
Bacterial strains  
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The bacterial strains used in this study were B. abortus 544 (ATCC23448), a 
smooth virulent B. abortus biovar 1 strain and E. coli DH5α (Invitrogen, USA). B. 
abortus was cultured in Brucella broth (BD Bioscience, USA), overnight at 37 ℃ in 
a gyratory shaker maintained at 220 rpm. E. coli DH5α, were used to produce the 
necessary plasmid constructs; cultures were routinely grown at 37 °C in Luria-
Bertani (LB) broth (Duchefa, Netherland) or agar supplemented with ampicillin 
(Sigma, USA). When solid medium and ampicillin were required, the above media 
were supplemented with 1.5 % (w/v) agar (Takara, Japan) and 100 μg/ml of 
ampicillin (Sigma, USA). 
 
Expression and purification of rOMP10, rOMP19, rTbpA, rRocF and rMdh 
proteins 
The expression and purification of recombinant proteins was accomplished with 
a brief modification to a previously described [Sung et al., 2014; Im et al., 2016b]. 
Briefly, 20 ml of overnight cultured plasmid harboring E. coli was inoculated into 1 
liter of LB broth containing ampicillin (25 μg/ml) and cultured at 37 °C for 7 h. 
Protein expression was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG, 
Amresco, USA) at a final concentration of 0.3 mM. Cells were then incubated at 
37 °C for 2 h and harvested by centrifugation at 4,400 x g for 20 min. Cell pellets 
were resuspended in 40 ml column buffer (20 mM TrisHCl, 8 M Urea, 500 mM NaCl, 
20 mM Imidazole, 1 mM β-mercaptoethanol, pH 8.0), sonicated at 10,000 Hz in an 
ice-water bath, and centrifuged at 4,400 x g for 20 min. Supernatants were loaded 
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onto a His SpinTrap (GE Healthcare, UK) column in accordance with the 
manufacturer’s instructions. Purified proteins were stored at -20 °C until required. 
 
SDS-PAGE and Western blot 
SDS-PAGE and Western blotting were performed with the recombinant proteins. 
Briefly, the purified recombinant proteins were diluted with sample buffer and boiled 
for 10 min at 100 °C. After electrophoresis, samples were visualized by staining with 
Coomassie Brilliant Blue R-250 (Intron, Korea). Proteins resolved by SDS-PAGE 
were transferred to nitrocellulose membrane (invitrogen, USA) for 25 min using an 
iBlot© transfer device (Invitrogen, USA). Membranes were blocked by incubating 
in 5 % skim milk (BD, USA) for 1 h at room temperature (RT) and washed 3 times 
with washing buffer (TBS) then, they were incubated with anti-histidine (1:2,000 
dilution, AprilBio Co., Ltd, Korea) for 3 h at RT. The membranes were washed 3 
times (10 min each) with the same washing buffer, after which they were incubated 
with alkaline phosphatase (AP)-conjugated goat anti-mouse IgG antibody (1:2,000 
dilution, Bethyl, USA,) for 1 h at room temperature. After final washing, the proteins 
were visualized using on AP conjugate substrate kit (Bio-Rad, USA). 
 
Human leukemic monocyte cell, THP-1, culture 
The THP-1 human leukemic monocyte cell line was procured from the Korea Cell 
Line Bank (KCLB, Seoul, Korea), and cultured in RPMI 1640 medium 
supplemented with 10 % fetal bovine serum (FBS; Gibco, OK, USA) and antibiotic–
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antimycotic solution (Sigma, MO, USA), at 37 °C in humidified air under 5 % CO2. 
The THP-1 cells were differentiated into macrophages by stimulation with phorbol-
12-myristate-13-acetate (PMA; Sigma, USA) (50 ng/ml) for 72 h, washed with FBS-
free RPMI 1640 medium and incubated in 5 % FBS-RPMI 1640 medium without 
antibiotics for 24 h before the experiments. 
 
Production of cytokines and expression of Toll-like receptors in THP-1 cells 
ELISA was performed to evaluate 4 cytokines in the cell culture supernatant. The 
differentiated THP-1 macrophage cells (1 x 106 cells/ml) were stimulated with five 
B. abortus antigens (10 ug/well). The purified recombinant proteins were treated 
with polymyxin B (10 μg/ml) for 30 min before stimulation of cells. LPS (10 μg/ml, 
Sigma, USA) was included as positive control. It was slightly modified our previous 
studies [Sung et al., 2014; Im et al., 2016b]. The culture supernatants were collected 
at 12 and 24 h after stimulation. The amounts of TNF-α, IL-6, IL-1β and IFN-γ were 
measured by ELISA according to the manufacturer’s instructions (ThermoFisher, 
USA). Expression of TLRs in THP-1 macrophages was measured by quantitative 
real-time PCR. cDNA was synthesized from 1 μg of total RNA from each stimulated 
sample using a Quantitect® Reverse Transcription kit (Qiagen, Hilden, Germany), 
after which quantitative real-time RT–PCR was performed with 2 μl of cDNA using 
the Rotor-Gene SYBR Green PCR kit (Qiagen, Germany) and Rotor-Gene Q real-
time PCR cycler (Qiagen, Germany) according to the manufacturer’s protocols. The 
reaction mixture consisted of 10 μl of 2X Rotor-Gene SYBR Green PCR Master Mix, 
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2 μl of primers, 2 μl of template DNA or cDNA, and 6 μl of RNase-free water. The 
real-time PCR conditions for two TLR genes (TLR4 and TLR8), MyD88 and 
interferon regulatory factor 4 (IRF4) were used as follows: initial denaturation at 
95 °C for 5 min followed by 45 cycles of 95 °C for 20s and annealing at 60 °C for 
10s (Table 6). The gene expression level was normalized against expression of the 
beta-actin gene using the 2−ΔΔCt formula, and relative expression levels of the target 
genes were compared with the control to determine changes in the fold expression 
of each gene. 
 
Statistical analysis 
Statistical significance (P-value) was calculated using the Student t test with the 
Statistical Package for Social Science (SPSS) software version 4.0 (MS, USA). 
Differences were considered to be significant if a value of P < 0.05. All experiments 





Production levels of five recombinant proteins 
Based on previous studies, five highly immunogenic cellular antigens of B. 
abortus were selected for evaluation from B. abortus antigens [Simborio et al., 2015; 
Im et al., 2016b; Reyes et al., 2016; Im et al., 2017]. Cloning of genes encoding Mdh, 
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OMP10, OMP19, RocF and TbpA was achieved as per a previous protocol, with a 
few modifications [Simborio et al., 2015; Im et al., 2016b; Im et al., 2017]. B. 
abortus antigens were purified by a histidine column after expression of a trigger 
factor (TF) fusion protein using the TF cloning system. The SDS-PAGE profiles of 
the purified rOMP10, rOMP19, rTbpA, rRocF, and rMdh proteins were 
approximately 65.86 kDa, 71 kDa, 88.76 kDa, 85.19 kDa and 85.71 kDa in size, 
respectively (Figure 28A). Western blotting was also performed to confirm the 
specificity of the expressed proteins after protein purification, and the expected sizes 
of rMdh, rOMP10, rOMP19, rRocF, and rTbpA were evaluated (Figure 28B). 
 
Production of cytokines in human leukemic monocytes cells, THP-1 
Culture supernatants of THP-1 cells were assayed by ELISA for TNF-α, IL-1β, 
IFN-γ and IL-6 production at 12 and 24 h after stimulation with rOMP10, rOMP19, 
rTbpA, rRocF and rMdh. The amount of TNF-α after stimulation with three B. 
abortus antigens (rOMP19, rTbpA and rMdh) was higher than the group stimulated 
with TF (Control) at 12 h. At 24 h post stimulation, four B. abortus antigen groups 
(rOMP19, rTbpA, rRocF and rMdh) showed significantly high production levels of 
TNF-α compared to the TF group (P < 0.01) (Figure 29A). Similarly, a significant 
amount of IL-6 was produced in the three B. abortus antigens exposure groups 
(rTbpA, rRocF and rMdh) at 12 h, whereas stimulation with all B. abortus antigens 
showed high production levels of IL-6 at 24 h, compared to the TF group (P < 0.05) 
(Figure 29D). However, production levels of the other cytokines (IL-1β and IFN-γ) 
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were not significant when compared to the TF group and the other B. abortus antigen 
groups (Figure 29B, C). These results indicate that the five B. abortus antigens 
possess the Th1 and/or Th2 immune-stimulating properties in THP-1 cells, resulting 
in the production of TNF-α and IL-6. Furthermore, stimulation by two B. abortus 
antigens (rTbpA and rMdh) consistently induces the production of both cytokines 
(TNF-α and IL-6) in a time dependent manner, compared to the TF group. 
 
Expression of TLRs in human leukemic monocyte cells, THP-1  
THP-1 cells were harvested after stimulation with the five B. abortus antigens. 
RNA was isolated, followed by cDNA synthesis using the RNA template. Real-time 
PCR from TLR1 to TLR10 was performed to confirm expression levels of TLRs 
after stimulation with B. abortus antigens. Of the expression of TLRs, the expression 
of TLR3, TLR4, TLR7 and TLR8 were significantly increased after the stimulation 
of THP-1 cells by B. abortus antigens. Other TLRs did not show significant 
difference in the expression (data not shown). Expression of TLR3 was lower than 
that of TF at 12 h after stimulation with five B. abortus antigens. The expression 
levels of the four protein stimulating groups (rOMP10, rOMP19, rTbpA and rRocF) 
showed low expression levels except for the experimental group stimulated with 
rMdh until after 24 h (Figure 30A). At 12 h post stimulation, the expression of TLR4 
was induced by two B. abortus antigens (rOMP10 and rRocF) (Figure 30B), whereas 
TLR8 expression was induced after stimulation with rOMP19 and rMdh (Figure 
30D). In addition, TLR7 expression was observed to be higher in all experimental 
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groups at 24 h after stimulation with B. abortus antigens than the control group 
(Figure 30C). Expression of the MyD88 gene, which plays an important role in the 
TLRs signaling pathway, was also analyzed by real-time PCR. No significant 
difference were observed in the MyD88 gene expression between the experimental 
groups stimulated with B. abortus antigens and control group stimulated with TF 
protein (Figure 30E). The expression of IFN-γ regulatory factor (IRF) is one of the 
factors involved in the TLR signal pathway in cells. IRF4, a known inhibitor of IRF5, 
showed different expression levels in THP-1 cells stimulated with the five B. abortus 
antigens. rTbpA and rMdh induced higher expression levels of IRF4 than the TF 
group at 12 h after stimulation in THP-1 cells (Figure 30F). Furthermore, the rTbpA 





The five B. abortus antigens used in this study have already been shown to have 
significant potent of immunogenicity in other studies [Simborio et al., 2015; Im et 
al., 2016b; Im et al., 2017]. Each B. abortus antigens exhibits the following 
characteristics. rOMP10 and rOMP19 have been reported to have high efficacy in 
serologic evaluation and immune response studies [Tibor et al., 1999; Simborio et 
al., 2015]. rTbpA is known as a protein involved in metabolism in brucellosis [Im et 
al., 2016b]. rRocF, arginase, is an enzyme that converts the substrate of iNOS 
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(arginine) into urea. rMdh is a protein involved in carbohydrate transport and 
metabolism and is known to be expressed by acidic stress [Lee et al., 2015; Im et al., 
2017]. When THP-1 cells were stimulated with these B. abortus antigens, most of B. 
abortus antigens in the production levels of cytokines were higher than the control. 
However, when the results of cytokine production and TLR expression were 
integrated, rOMP19 and rMdh were found to be more promising candidates for 
analysis of immune response after stimulation. 
It is important to observe changes in intracellular signal transduction and cytokine 
production during intracellular infection of Brucella spp. Numerous research groups 
have studied the immune response and new diagnostic candidates with LPS-free 
cellular components of B. abortus [Fu et al., 2012; Lim et al., 2012; Im et al., 2017]. 
Various B. abortus cellular components, such as outer membrane proteins and 
cellular antigens, are effective for inducing of immune responses in vitro and in vivo 
[Lim et al., 2012; Sung et al., 2014; Simborio et al., 2015; Im et al., 2016b; Im et 
al., 2017; Li et al., 2018]. The induction of immune responses was assessed by 
analyzing the production levels of cytokines in the target cells after stimulation with 
bacterial pathogens. The intracellular immune response induces Th1 (cellular) or 
Th2 (humoral) immune response, depending on the role of the produced cytokines. 
The TNF-α and IFN-γ cytokines induce a Th1 immune response, whereas IL-6 elicits 
a Th2 immune response. Moreover, IL-6 has recently been shown to induce Th17 
[De la Cruz-Mosso et al., 2017; Zhao et al., 2018]. In addition, comparative analysis 
of expression levels of IL-1β, IL-12 and IL-18, which are typical for inducing 
 - 113 - 
inflammatory responses in cells, has been widely used as an index for evaluating 
innate immunity. These results indicate that the cytokine production varied, 
depending on the cellular antigens of B. abortus. The production levels of TNF-α 
and IL-6 were higher than the other cytokines (IL-1β and IFN-γ) in THP-1 cells 
stimulated with B. abortus antigens. This is similar to previous studies that reported 
cytokine production profiles in mouse macrophages, RAW 264.7 cells stimulated 
with B. abortus cellular antigens [Sung et al., 2014; Im et al., 2016b]. Moreover, our 
results might help to reveal the inherent mechanisms of Brucella infection, and the 
efficiency and immunogenicity of B. abortus cellular antigens.  
Toll-like receptors are involved in intracellular signal transduction. Of the toll-like 
receptors studied, TLR2 and TLR4 in mice have an important effect on 
proinflammatory cytokine expression and cytotoxic T cell production from Brucella 
infection [Arias et al., 2017]. In contrast, MyD88 present in the downstream of the 
TLR signaling pathway plays an important role in inducing immune responses in 
various cells such as lung, liver, and spleen. It is especially important in the spleen 
for controlling the immune response [Arias et al., 2012]. TLR signal transduction is 
also important in studies using the human macrophage cells, THP-1 cells. TLR1 and 
TLR6 have been reported to affect the activity of nuclear factor kappa B (NF-κB) 
after infection of pathogens [Shimizu et al., 2008]. TLR8 plays an important role in 
inducing external antigen recognition and autoimmunity [Gantier et al., 2010], and 
is also known to be expressed intracellularly. Specifically, it is activated by 
exogenous viral ssRNA, endogenous RNA, bacterial RNA and selfRNAs released 
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from dead or dying cell. Also, it is activated by bacterial RNA in human monocytes 
[Jorge et al., 2012]. Furthermore, TLR8 recognize uridine-rich ssRNA certain 
chemical compounds with their distinct sites [Tanji et al., 2015]. In this study, the 
difference in expression of TLR3, TLR4, TLR7 and TLR8 was dependent on the B. 
abortus antigens. However, in the overall TLR expression, the TLR8 expression is 
highly induced compared to TLR4 expression, which was assessed by evaluating the 
induction of immunity in THP-1 cells after stimulation with B. abortus antigens in 
this study. TLR8 is expressed in various tissues, with its highest expression in 
monocytes, and is upregulated after bacterial infection. Moreover, the expression of 
TLR3 and TLR7 in the endosome, TLR3 expression was lower than the control, 
whereas TLR7 expression was higher. TLR3 generally induces NF-kB activity and 
cytokine expression through recognition of dsRNA and viruses. [Gomes et al., 2012]. 
TLR7, some cases known to recognize the same ligand as TLR8, is known to 
recognize ssRNA and a nucleic acid-like structure of the virus [Kawai et al., 2010]. 
Thus, TLR3, TLR4 and TLR7 are activated by Brucella infection and induce an 
immune response [Gomes et al., 2012]. Interferon regulatory factor (IRF) 5 and 7 
are known to interact with MyD88 and induce proinflammatory cytokines and type 
I interferons [Honda et al., 2004; Takaoka et al., 2005]. In contrast, IRF4 is known 
to interfere with the TLR signaling by competitively competing with the IRF5 to 
bind to MyD88 [Negishi et al., 2005]. 
In conclusion, this study revealed that the five B. abortus antigens stimulate the 
immune activity in THP-1 cells. Of the B. abortus antigens, rOMP19 and rMdh 
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showed more effective activity than the others. These results indicate that two B. 
abortus antigens are possible candidates for further investigation in the pathogenesis 
of Brucella infection, and can be potential candidates for implementing measures to 
control the infection.  
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Table 6. Nucleotide sequence of primers used in this study 





















































60 117 [Li et al., 2013] 
R: CGTATGTCCATGGGAGATCCG 
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Figure 28. Analysis of Brucella abortus recombinant cellular proteins by SDS-
PAGE (A) and Western blot (B). Lane 1: Control (TF; 52 kDa), Lane 2: rOMP10 
(65.86 kDa), Lane 3: rOMP19 (71 kDa), Lane 4: rTbpA (88.76 kDa), Lane 5: rRocF 
(85.19 kDa), Lane 6: rMdh (85.71 kDa).  
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Figure 29. The production of cytokines in THP-1 cells (A) TNF-α, (B) IL-1β, (C) 
IFN-γ and (D) IL-6, after stimulation with B. abortus antigens. TNF-α production 
was induced after stimulation with rOMP19, rTbpA and rMdh at 12 h and rOMP19, 
rTbpA, rRocF and rMdh at 24 h. IL-6 production was induced after stimulation with 
rTbpA, rRocF and rMdh at 12 h and rOMP10, rOMP19, rTbpA, rRocF and rMdh at 
24 h. Production of IL-1β and IFN-γ were not significantly induced at 12 and 24 h 
after stimulation with B. abortus antigens except the production of IL-1β at 24 h after 
stimulation with rRocF. (* P < 0.05, ** P < 0.01).  
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Figure 30. The expression of (A) TLR3, (B) TLR4, (C) TLR7, (D) TLR8, (E) 
MyD88 and (F) IRF4 in THP-1cells after stimulation with B. abortus antigens. TLR3 
expression was lower than that of TF at 12 and 24 h except for the expression level 
in the experimental group stimulated with rMdh. TLR4 expression increased after 
stimulation with rOMP10 and rRocF at 12 h. TLR7 expression was higher in all 
experimental groups than the control group at 24 h. TLR8 expression increased after 
stimulation with rOMP19 and rMdh at 12 h. The production of IRF4 increased at 12 
h after stimulation with rTbpA and rMdh then decreased at 24 h. (* P < 0.05, ** P < 
0.01).  
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General Conclusions  
 
In an effort to solve the economic and social problems that arise from the onset of 
brucellosis, investigation of Brucella is steadily being conducted. Particularly, 
attempts to diagnose or prevent brucellosis through the early diagnosis of Brucella 
infection and the development of a vaccine have been continued by several 
researchers. Among these studies, efforts to develop diagnostic methods and 
vaccines using recombinant proteins of Brucella have become one of potent part of 
this area. In this study, Brucella abortus cellular antigens were used to stimulate 
various immune cells, analyze immune responses in each, and demonstrate excellent 
immunogenicity after stimulation with the antigens. 
 
1. After stimulation of bPBMC with B. abortus antigens, the immune response was 
analyzed by gene expression of cytokines and apoptosis-related genes. As a result, it 
was observed that bPBMC can induce an appropriate immune response regardless 
of apoptosis. Although the gene expressions of iNOS, TNF-α and IL-1β were not 
effective on bPBMC by the stimulation of B. abortus antigens, the gene expressions 
of IL-6, IL-12p40 and IFN-γ were significantly increased. These results indicate that 
the adaptive immune system is effectively activated in bPBMC by the stimulation of 
B. abortus antigens. In addition, it was confirmed that the expression of Bax and Bcl-
2, which are apoptotic genes, is not affected except the expression of TLR4. 
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Therefore, B. abortus antigens are thought to induce an effective adaptive immune 
response in both humoral and cellular immunity without inducing an apoptosis. 
 
2. In order to evaluate the immunogenicity of B. abortus antigens, rMdh, rRocF and 
rTsf, RAW 264.7 cells were stimulated the antigens. Also, the immune response was 
analyzed at BALB/c mice after immunization the antigens. As a result, in vitro test 
results showed that all three B. abortus antigens induce immune response in the cells. 
Especially, mouse splenocyte showed high expression of IFN-γ and IL-2 when 
stimulated with rMdh and rTsf. In vivo experiments indicated that IFN-γ- and IL-4-
secreting cells were highly expressed, and that total IgG production was also elevated 
time-dependent after immunization (P < 0.05). These results showed that all of the 
three B. abortus antigens were able to confirm the potential as a high immunogenic 
antigen and induce the Th2 immune response well in vivo. 
 
3. It was confirmed that TNF-α and IL-6 were highly produced by stimulation with 
B. abortus antigens, rOMP10, rOMP19 and rOMP28 in RAW 264.7 cells. 
Particularly, NO production level showed high at 24 h after the stimulation with 
rOMP19, and IFN-γ and IL-2 production were higher after the stimulation with 
rOMP28 compared to other B. abortus antigens. It is indicating that rOMP28 is 
expected to induce a Th1 immune response. In vivo experiments also confirmed that 
the three B. abortus antigens exhibited high IgG production. However, there was no 
difference in the production of IFN-γ- and IL-4-expressing T cells (P < 0.05). 
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Nevertheless, it shows the potential of the three B. abortus antigens as antigens by 
inducing immune responses that differ in the production of cytokines and IgG in 
vitro and in vivo. 
 
4. Five of B. abortus antigens, which are already highly immunogenic, were selected 
and examined for immune responses in THP-1 cells after the stimulation. In the 
cytokine production, the productions of TNF-α and IL-6 were higher than that of IL-
1β and IFN-γ, which is similar to that in RAW 264.7 cells. In addition, real-time PCR 
confirmed the difference in the immune response by confirming changes in TLR 
expression. As a result, TLR3, -4, -7 and -8 showed different expression depending 
on B. abortus antigens. Especially, TLR8 was highly expressed at 12 h in the 
rOMP19 and rMdh stimulation groups. In addition, it was confirmed that TLR4 
expression was low in B. abortus antigen groups (rTbpA and rMdh), which showed 
a high expression of IRF4, which interferes with the binding of MyD88 and IRF5 
involved in TLR4 signaling (P < 0.05). Therefore, these two B. abortus antigens, 
rOMP19 and rMdh, showed the possibility for the high immunogenicity candidates 
in THP-1 cells, and further research on these two B. abortus antigens should be 
needed.  
 
In conclusion, significant differences are showed with the expression of cytokines, 
IL-6, IL-12p40, and IFN-γ, in bPBMC, the productions of TNF-α and IL-6 in both 
RAW 264.7 and THP-1 cells after stimulation with B. abortus antigens. These results 
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indicated that a similar production of cytokines is induced after stimulation with the 
B. abortus antigens through analysis of the immune response of different host 
immune cells. In addition, different immune responses were observed depending on 
the B. abortus antigens in each host immune cells. In particular, among the B. abortus 
antigens used in this study, rMdh and rOMP19 showed high immunogenicity. 
Specifically, the immune responses of different immune cells, bPBMC, RAW 264.7 
and THP-1 cells, were confirmed to be high in all experimental groups after 
stimulation with rMdh. Also, the rOMP19 stimulated groups showed high 
immunogenicity in RAW 264.7 and THP-1 cells. Therefore, these highly 
immunogenic antigens might be used for the development of brucellosis diagnosis 
and vaccine using the Brucella antigens. In addition, when the same B. abortus 
antigens are selected and the immune responses generated through different host 
immune cell stimuli were analyzed, it is considered that the antigen material 
exhibiting better immunogenicity can be selected. Therefore, the analysis of the host 
immune response using the B. abortus antigens could be an important step in the 
diagnosis, prevention and evaluation of the characteristics of brucellosis.  
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국문초록 
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브루셀라증은 브루셀라 속균감염에 의해 지속적으로 발생되고 있는 주
요한 인수공통전염병 중 하나이다. 특히, Brucella abortus는 소에서 유•사
산, 불임등의 번식장애를 사람에서는 파상열, 심내막염, 관절염, 및 골수
염을 유발한다. 이러한 B. abortus는 유•사산된 태아, 태반, 양수 및 감염
동물의 유선을 통해서 배출된다. B. abortus의 감염은 유•사산물과의 직•간
접적인 접촉 또는 멸균되지 않은 유제품의 섭취등에 의해서 이루어질 수 
있다. 
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다양한 경로를 통하여 숙수세포에 침투한 B. abortus는 숙주세포의 면
역기전을 회피하기 위한 자가보호시스템을 구축하고 있으며, Brucella-
containing vacuole (BCV), Type Ⅳ secretion system (T4SS), Cyclic β-1,2-glucan 
(cβG), Brucella lipopolysaccharide (Br-LPS)등의 여러가지 요소들을 이용하여 
세포내에서의 생존/복제가 가능하다. 또한, 숙주세포에서 면역반응으로 
발현되는 사이토카인의 발현을 조절하기 위하여 다양한 대식세포들의 신
호전달체계를 방해한다. 이러한 세포내 침입과 생존/복제가 가능한 브루
셀라의 예방 및 근절을 위하여 많은 연구가 진행되었다. 특히, 숙주세포 
침입기전 분석 및 면역학적 특성 분석에 관한 연구에 많이 집중되었다.  
현재 브루셀라의 초기 감염을 진단하기 위한 노력은 지속되고 있으며 
B. abortus 감염시 강력한 면역반응을 유발시키는 B. abortus 항원들이 진
단항원으로써 주목을 받고 있다. 본 연구에서는 이러한 B. abortus 세포 
항원들을 서로 다른 동물유래의 면역세포에서 면역유도능력을 사이토카
인과 면역관련 유전자의 발현차이로 비교하여, B. abortus 감염증 예방을 
위해 발병기전, 최적의 진단법 및 백신항원후보물질 발굴을 위한 기초 
자료를 제공하고자 하였다.  
첫번째로, 소의 말초혈액단핵세포(PBMC)의 면역반응 양상을 알아보고
자 IL-1β, IL-4, IL-6, IL-12p40, IFN-γ, TNF-α 및 iNOS의 발현을 확인하였다. 
또한, 세가지 세포사멸 관련 유전자인 Bax, Bcl-2 및 TLR4의 발현을 B. 
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abortus 항원(rMdh, rOMP28, rRocF, rTsf and r0628) 자극에 의한 면역세포의 
반응을 통하여 분석하였다. 각 B. abortus 항원은 자극 시간 및 투여량에 
따라 사이토카인 발현양상은 상이하게 나타났다. 즉, IL-1β, IL-4, TNF-α 및 
iNOS 유전자 발현은 관찰되지 않았지만, IL-6, IL-12p40 및 IFN-γ의 발현
은 모든 B. abortus 항원 자극으로 유도되었다(P < 0.05). 세포사멸 관련 유
전자의 발현은 TLR4 외에 변화가 없었다(P < 0.05).  
두번째로, 마우스 유래의 면역세포인 RAW 264.7 세포 및 마우스에 B. 
abortus 항원(rMdh, rOMP10, rOMP19, rOMP28, rRocF and rTsf)을 자극하여 
면역반응의 차이를 분석하였다. 사이토카인 발현은 B. abortus 항원으로 
RAW 264.7 세포와 비장세포를 자극시킨 후 조사하였다. 면역 반응은 B. 
abortus 항원(rMdh, rOMP10, rOMP19, rOMP28, rRocF and rTsf)으로 마우스를 
면역시킨 후 ELISA 및 ELISpot을 통하여 비교분석하였다. 자극된 RAW 
264.7 세포에서는 TNF-α와 IL-6 발현이 증가하였고(P < 0.05), 비장세포에
서는 Th1 관련 사이토카인 IFN-γ와 IL-2가 유도되었다(P < 0.01). 또한, 마
우스 면역에 따른 생체내 면역반응을 IgG 분비 세포의 발현 차이를 분
석함으로 B. abortus 항원에 따라 유도되는 면역반응을 비교한 결과 면역 
후 28일째 IgG의 발현이 현저하게 증가하는 것을 관찰할 수 있었다(P < 
0.05).  
마지막으로, 사람유래 면역세포인 THP-1 세포를 B. abortus 항원(rMdh, 
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rOMP10, rOMP19, rRocF and rTbpA)으로 자극하여 발생하는 면역반응의 차
이를 확인하였다. 특히, 사이토카인과 Toll-like receptors (TLRs) 같은 선천
성 면역을 조절하고, 감염 후 숙주가 면역을 획득하는데 중요한 역할을 
하는 주요 조절인자들의 발현차이에 초점을 맞추어 진행하였다. B. 
abortus 항원으로 THP-1 세포를 자극 시킨 후, ELISA 및 real-time RT-PCR
을 사용하여 사이토카인 생성 및 TLR 발현량을 두시점(12 및 24시간)에
서 정량, 비교분석하였다. 사이토카인 생성에 있어서, B. abortus 항원으로 
자극된 THP-1 세포에서 TNF-α 및 IL-6의 발현량이 높게 유도되었다(P < 
0.05). 또한, TLR8은 rOMP19 및 rMdh로 자극 후 12시간에 대조군에 비해 
유의한 발현증가를 나타냈다. 이러한 결과는 두 개의 B. abortus 항원인 
rOMP19와 rMdh가 THP-1 세포에서의 TLR8 발현유도에 관한 추가 연구
의 필요성을 시사한다.  
B. abortus 항원(rMdh, rOMP10, rOMP19, rOMP28, rRocF, rTbpA, rTsf and 
r0628)을 이용한 서로 다른 동물유래 면역세포들의 면역반응 연구결과를 
종합하면, 본 연구에 사용된 B. abortus 항원들 중 고면역원성을 나타내는 
수종의 B. abortus 세포 항원이 확인되었다. 이들 B. abortus 항원 중 rMdh
와 rOMP19는 높은 면역원성을 나타내었다. 특히, rMdh는 본 연구에서 사
용한 모든 동물유래 면역세포에 대해 고면역원성을 보였다. 본 연구를 
통하여 B. abortus 항원의 세포내 면역반응 조절인자로서의 활성뿐 아니
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라 고면역원성 항원 후보물질로서의 가능성을 확인할 수 있었으며, 이러
한 연구결과는 향후 B. abortus 감염증 예방을 위한 진단법 개발 및 백신
후보물질 발굴을 위한 기초자료로 유용할 것으로 사료된다. 
   
핵심어: 브루셀라증, 브루셀라, B. abortus 항원, 면역반응, Th1, Th2, 사이토
카인, 면역세포. 
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